| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ethanol binding | 3.96e-08 | 6 | 145 | 4 | GO:0035276 | |
| GeneOntologyMolecularFunction | actin filament binding | MYH3 MYH8 MYH10 MYH11 MYO7A SPTB ANXA8L1 ANXA8 ITPRID2 PLEC FSCN1 MARCKS | 1.04e-07 | 227 | 145 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH3 MYH8 MYH10 MYH11 MYO7A CAMK2A CAMK2D EWSR1 RYR1 MAPKAPK3 MARCKS | 9.75e-07 | 230 | 145 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | NAD binding | 1.01e-06 | 73 | 145 | 7 | GO:0051287 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP5F1E MYH3 MYH8 MYH10 MYH11 WAPL CENPE MYO7A ATP6V1G1 YTHDC2 ARID1A BPTF MSH6 NAV3 DHX29 TOP2B ATP5F1EP2 | 2.40e-06 | 614 | 145 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | microfilament motor activity | 7.80e-06 | 38 | 145 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 2.53e-05 | 24 | 145 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 3.52e-05 | 26 | 145 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.98e-05 | 127 | 145 | 7 | GO:0016616 | |
| GeneOntologyMolecularFunction | actin binding | MYH3 MYH8 MYH10 MYH11 MYO7A SPTB ANXA8L1 ANXA8 ITPRID2 P4HB PLEC FSCN1 MARCKS | 4.82e-05 | 479 | 145 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 6.31e-05 | 30 | 145 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 6.75e-05 | 138 | 145 | 7 | GO:0016614 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH3 MYH8 MYH10 MYH11 CENPE MYO7A CETN2 CAMK2D SPTB APC2 ANXA8L1 ANXA8 ITPRID2 TIAM1 P4HB CEP135 NAV3 PLEC FSCN1 MARCKS | 1.36e-04 | 1099 | 145 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.23e-04 | 118 | 145 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 9.65e-04 | 27 | 145 | 3 | GO:0004683 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 1.42e-03 | 8 | 145 | 2 | GO:0003916 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 3.40e-07 | 3 | 145 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 3.37e-06 | 5 | 145 | 3 | GO:0006117 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 6.64e-06 | 18 | 145 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 1.26e-05 | 73 | 145 | 6 | GO:1901616 | |
| GeneOntologyBiologicalProcess | organelle assembly | CFAP47 MYH3 CLUAP1 MYH10 MYH11 CENPE MYO7A CETN2 CASQ1 CASQ2 CEP128 KIAA0753 FSIP2 HAUS1 VPS33B CEP135 TEKT1 AP1M1 PLEC FSCN1 CPLANE1 DHX29 | 1.50e-05 | 1138 | 145 | 22 | GO:0070925 |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 1.94e-05 | 47 | 145 | 5 | GO:0046164 | |
| GeneOntologyBiologicalProcess | modification of postsynaptic actin cytoskeleton | 2.23e-05 | 24 | 145 | 4 | GO:0098885 | |
| GeneOntologyBiologicalProcess | cell cycle process | ZWILCH MYH10 WAPL CENPE CETN2 CAMK2A CAMK2D POLE RTF2 HJURP HSF2BP YTHDC2 ARID1A BIRC6 KIAA0753 MSH6 HAUS1 CEP135 MKI67 GIGYF2 SMARCD3 PLEC TOP1 TOP2B ANAPC4 | 2.32e-05 | 1441 | 145 | 25 | GO:0022402 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MYH3 MYH10 MYH11 CENPE CETN2 CASQ1 CASQ2 KIAA0753 HAUS1 CEP135 PLEC FSCN1 DHX29 | 3.18e-05 | 475 | 145 | 13 | GO:0140694 |
| GeneOntologyBiologicalProcess | myofibril assembly | 3.22e-05 | 86 | 145 | 6 | GO:0030239 | |
| GeneOntologyBiologicalProcess | retinol metabolic process | 3.50e-05 | 53 | 145 | 5 | GO:0042572 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 3.91e-05 | 89 | 145 | 6 | GO:0055002 | |
| GeneOntologyBiologicalProcess | DNA topological change | 3.94e-05 | 10 | 145 | 3 | GO:0006265 | |
| GeneOntologyBiologicalProcess | regulation of modification of postsynaptic actin cytoskeleton | 7.15e-05 | 12 | 145 | 3 | GO:1905274 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | MYH3 MYH10 MYH11 CAMK2D ADGRB1 CASQ1 CASQ2 ADAMTS5 ARID1A RYR1 SMARCD3 PLEC SOD2 | 9.86e-05 | 531 | 145 | 13 | GO:0042692 |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | MYH3 MYH10 MYH11 CAMK2D ADGRB1 CASQ1 CASQ2 ADAMTS5 ARID1A RYR1 PLEC | 1.03e-04 | 391 | 145 | 11 | GO:0051146 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.29e-04 | 37 | 145 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | negative regulation of phospholipase A2 activity | 1.47e-04 | 3 | 145 | 2 | GO:1900138 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.59e-04 | 39 | 145 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | modification of postsynaptic structure | 2.13e-04 | 42 | 145 | 4 | GO:0099010 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 2.15e-04 | 17 | 145 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 2.15e-04 | 17 | 145 | 3 | GO:0006068 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 2.56e-04 | 44 | 145 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 2.88e-04 | 180 | 145 | 7 | GO:0120254 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 4.14e-04 | 89 | 145 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | modification of synaptic structure | 4.53e-04 | 51 | 145 | 4 | GO:0099563 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 4.54e-04 | 139 | 145 | 6 | GO:0051983 | |
| GeneOntologyBiologicalProcess | chromosome segregation | ZWILCH WAPL CENPE HJURP ARID1A HAUS1 MKI67 SMARCD3 TOP1 TOP2B ANAPC4 | 4.58e-04 | 465 | 145 | 11 | GO:0007059 |
| GeneOntologyBiologicalProcess | regulation of modification of postsynaptic structure | 4.75e-04 | 22 | 145 | 3 | GO:0099159 | |
| GeneOntologyBiologicalProcess | negative regulation of phospholipase activity | 4.84e-04 | 5 | 145 | 2 | GO:0010519 | |
| GeneOntologyBiologicalProcess | muscle cell development | 5.03e-04 | 259 | 145 | 8 | GO:0055001 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 5.32e-04 | 94 | 145 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 5.44e-04 | 23 | 145 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 5.59e-04 | 95 | 145 | 5 | GO:0030071 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 5.89e-04 | 146 | 145 | 6 | GO:0051209 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 5.99e-04 | 266 | 145 | 8 | GO:0033044 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 6.10e-04 | 147 | 145 | 6 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 6.44e-04 | 98 | 145 | 5 | GO:1902099 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 6.55e-04 | 149 | 145 | 6 | GO:0051282 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 7.06e-04 | 100 | 145 | 5 | GO:0007091 | |
| GeneOntologyBiologicalProcess | NMDA selective glutamate receptor signaling pathway | 7.23e-04 | 6 | 145 | 2 | GO:0098989 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 7.53e-04 | 153 | 145 | 6 | GO:0051208 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 7.53e-04 | 153 | 145 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 7.90e-04 | 59 | 145 | 4 | GO:0045214 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 8.07e-04 | 103 | 145 | 5 | GO:0044784 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 8.33e-04 | 156 | 145 | 6 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 8.33e-04 | 156 | 145 | 6 | GO:0010927 | |
| GeneOntologyCellularComponent | myosin filament | 2.44e-05 | 25 | 144 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 3.89e-05 | 28 | 144 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 5.37e-05 | 59 | 144 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.39e-04 | 114 | 144 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.68e-04 | 16 | 144 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | sperm head-tail coupling apparatus | 2.42e-04 | 18 | 144 | 3 | GO:0120212 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 2.58e-04 | 45 | 144 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | terminal cisterna | 2.80e-04 | 4 | 144 | 2 | GO:0014802 | |
| GeneOntologyCellularComponent | eukaryotic 43S preinitiation complex | 2.86e-04 | 19 | 144 | 3 | GO:0016282 | |
| GeneOntologyCellularComponent | proton-transporting two-sector ATPase complex, catalytic domain | 2.86e-04 | 19 | 144 | 3 | GO:0033178 | |
| GeneOntologyCellularComponent | translation preinitiation complex | 3.35e-04 | 20 | 144 | 3 | GO:0070993 | |
| GeneOntologyCellularComponent | sarcolemma | 3.54e-04 | 190 | 144 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | transcription export complex 2 | 4.65e-04 | 5 | 144 | 2 | GO:0070390 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 4.65e-04 | 5 | 144 | 2 | GO:0005954 | |
| GeneOntologyCellularComponent | proton-transporting ATP synthase complex, catalytic core F(1) | 6.94e-04 | 6 | 144 | 2 | GO:0045261 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.13e-03 | 30 | 144 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | junctional membrane complex | 1.64e-03 | 9 | 144 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum lumen | 1.64e-03 | 9 | 144 | 2 | GO:0033018 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 1.64e-03 | 9 | 144 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | ATPase complex | 2.01e-03 | 129 | 144 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 2.05e-03 | 10 | 144 | 2 | GO:0014701 | |
| MousePheno | abnormal ethanol metabolism | 1.34e-05 | 6 | 124 | 3 | MP:0005443 | |
| MousePheno | abnormal retinol metabolism | 2.32e-05 | 7 | 124 | 3 | MP:0005444 | |
| MousePheno | enhanced behavioral response to xenobiotic | 3.28e-05 | 69 | 124 | 6 | MP:0009746 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 4.58e-05 | 23 | 124 | 4 | MP:0004088 | |
| Domain | ADH_Zn_CS | 1.30e-09 | 8 | 142 | 5 | IPR002328 | |
| Domain | ADH_ZINC | 1.30e-09 | 8 | 142 | 5 | PS00059 | |
| Domain | PKS_ER | 9.67e-08 | 16 | 142 | 5 | IPR020843 | |
| Domain | ADH_N | 9.67e-08 | 16 | 142 | 5 | PF08240 | |
| Domain | PKS_ER | 9.67e-08 | 16 | 142 | 5 | SM00829 | |
| Domain | ADH_N | 9.67e-08 | 16 | 142 | 5 | IPR013154 | |
| Domain | - | 1.87e-07 | 18 | 142 | 5 | 3.90.180.10 | |
| Domain | ADH_zinc_N | 2.53e-07 | 19 | 142 | 5 | PF00107 | |
| Domain | ADH_SF_Zn-type | 2.53e-07 | 19 | 142 | 5 | IPR002085 | |
| Domain | ADH_C | 2.53e-07 | 19 | 142 | 5 | IPR013149 | |
| Domain | GroES-like | 8.96e-07 | 24 | 142 | 5 | IPR011032 | |
| Domain | Myosin_N | 4.10e-06 | 15 | 142 | 4 | PF02736 | |
| Domain | Myosin_N | 4.10e-06 | 15 | 142 | 4 | IPR004009 | |
| Domain | Myosin_tail_1 | 9.02e-06 | 18 | 142 | 4 | PF01576 | |
| Domain | Myosin_tail | 9.02e-06 | 18 | 142 | 4 | IPR002928 | |
| Domain | Myosin_head_motor_dom | 9.71e-06 | 38 | 142 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 9.71e-06 | 38 | 142 | 5 | PS51456 | |
| Domain | Myosin_head | 9.71e-06 | 38 | 142 | 5 | PF00063 | |
| Domain | MYSc | 9.71e-06 | 38 | 142 | 5 | SM00242 | |
| Domain | Myosin-like_IQ_dom | 1.14e-05 | 19 | 142 | 4 | IPR027401 | |
| Domain | - | 1.14e-05 | 19 | 142 | 4 | 4.10.270.10 | |
| Domain | - | 4.57e-05 | 169 | 142 | 8 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 5.39e-05 | 173 | 142 | 8 | IPR016040 | |
| Domain | AnnexinVIII | 5.74e-05 | 2 | 142 | 2 | IPR009115 | |
| Domain | Calsequestrin_CS | 5.74e-05 | 2 | 142 | 2 | IPR018233 | |
| Domain | Calsequestrin | 5.74e-05 | 2 | 142 | 2 | PF01216 | |
| Domain | EIF3C_N_dom | 5.74e-05 | 2 | 142 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 5.74e-05 | 2 | 142 | 2 | PF05470 | |
| Domain | CALSEQUESTRIN_1 | 5.74e-05 | 2 | 142 | 2 | PS00863 | |
| Domain | CALSEQUESTRIN_2 | 5.74e-05 | 2 | 142 | 2 | PS00864 | |
| Domain | EIF3C | 5.74e-05 | 2 | 142 | 2 | IPR027516 | |
| Domain | IQ_motif_EF-hand-BS | 6.40e-05 | 90 | 142 | 6 | IPR000048 | |
| Domain | IQ | 7.69e-05 | 93 | 142 | 6 | PS50096 | |
| Domain | IQ | 2.06e-04 | 71 | 142 | 5 | PF00612 | |
| Domain | CaMKII_AD | 3.41e-04 | 4 | 142 | 2 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 3.41e-04 | 4 | 142 | 2 | IPR013543 | |
| Domain | Calsequestrin | 3.41e-04 | 4 | 142 | 2 | IPR001393 | |
| Domain | IQ | 3.81e-04 | 81 | 142 | 5 | SM00015 | |
| Domain | Myosin_S1_N | 5.65e-04 | 5 | 142 | 2 | IPR008989 | |
| Domain | CSP | 1.56e-03 | 8 | 142 | 2 | SM00357 | |
| Domain | Cold_shock_prot | 1.56e-03 | 8 | 142 | 2 | IPR011129 | |
| Domain | CSD | 1.56e-03 | 8 | 142 | 2 | PF00313 | |
| Domain | CSP_DNA-bd | 1.56e-03 | 8 | 142 | 2 | IPR002059 | |
| Domain | CH | 1.99e-03 | 70 | 142 | 4 | PF00307 | |
| Domain | - | 2.10e-03 | 71 | 142 | 4 | 1.10.418.10 | |
| Domain | CH | 2.32e-03 | 73 | 142 | 4 | PS50021 | |
| Domain | - | 2.48e-03 | 10 | 142 | 2 | 4.10.1060.10 | |
| Domain | CH-domain | 2.56e-03 | 75 | 142 | 4 | IPR001715 | |
| Domain | Band_7 | 3.02e-03 | 11 | 142 | 2 | IPR001107 | |
| Domain | Band_7 | 3.02e-03 | 11 | 142 | 2 | PF01145 | |
| Domain | PHB | 3.02e-03 | 11 | 142 | 2 | SM00244 | |
| Domain | ANX | 4.24e-03 | 13 | 142 | 2 | SM00335 | |
| Domain | Annexin_repeat_CS | 4.24e-03 | 13 | 142 | 2 | IPR018252 | |
| Domain | Annexin | 4.24e-03 | 13 | 142 | 2 | PF00191 | |
| Domain | Annexin_repeat | 4.24e-03 | 13 | 142 | 2 | IPR018502 | |
| Domain | - | 4.24e-03 | 13 | 142 | 2 | 3.10.450.50 | |
| Domain | ANNEXIN | 4.24e-03 | 13 | 142 | 2 | PS00223 | |
| Domain | - | 4.24e-03 | 13 | 142 | 2 | 1.10.220.10 | |
| Domain | ARM-type_fold | 4.45e-03 | 339 | 142 | 8 | IPR016024 | |
| Domain | Annexin | 4.92e-03 | 14 | 142 | 2 | IPR001464 | |
| Domain | NTF2-like_dom | 5.65e-03 | 15 | 142 | 2 | IPR032710 | |
| Domain | PINT | 6.42e-03 | 16 | 142 | 2 | SM00088 | |
| Domain | PCI_dom | 7.24e-03 | 17 | 142 | 2 | IPR000717 | |
| Domain | DUF1605 | 7.24e-03 | 17 | 142 | 2 | IPR011709 | |
| Domain | PCI | 7.24e-03 | 17 | 142 | 2 | PF01399 | |
| Domain | OB_NTP_bind | 7.24e-03 | 17 | 142 | 2 | PF07717 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 1.01e-06 | 10 | 120 | 4 | MM15833 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 1.37e-06 | 42 | 120 | 6 | M699 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.57e-06 | 11 | 120 | 4 | MM15405 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 2.35e-06 | 12 | 120 | 4 | M14663 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 6.34e-06 | 15 | 120 | 4 | M39717 | |
| Pathway | REACTOME_ABACAVIR_ADME | 3.27e-05 | 8 | 120 | 3 | MM14869 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 8.22e-05 | 165 | 120 | 8 | MM15026 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 8.73e-05 | 28 | 120 | 4 | MM15188 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 9.32e-05 | 54 | 120 | 5 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 9.32e-05 | 54 | 120 | 5 | MM15202 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 1.32e-04 | 31 | 120 | 4 | M39714 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.90e-04 | 34 | 120 | 4 | M27556 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.10e-04 | 64 | 120 | 5 | M9488 | |
| Pathway | REACTOME_RAF_ACTIVATION | 2.13e-04 | 35 | 120 | 4 | MM15271 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.72e-04 | 105 | 120 | 6 | MM14842 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.41e-04 | 203 | 120 | 8 | M5485 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 4.35e-04 | 42 | 120 | 4 | M16743 | |
| Pathway | WP_RETINOL_METABOLISM | 5.21e-04 | 44 | 120 | 4 | MM15851 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 7.15e-04 | 21 | 120 | 3 | M47949 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 7.87e-04 | 49 | 120 | 4 | MM15186 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 8.23e-04 | 22 | 120 | 3 | M27445 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 WAPL CAMK2D POLE RTF2 U2AF2 YBX3 SRBD1 RRBP1 ARID1A BIRC6 PHB1 MEMO1 MSH6 GTF2I NOP14 UBN1 VPS33B P4HB MCM3AP MKI67 AP1M1 HADHA PLEC FSCN1 DHX29 TOP1 TOP2B STOML2 SORD | 6.17e-14 | 1353 | 146 | 30 | 29467282 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ELOA MYH10 WAPL CETN2 BCLAF1 U2AF2 EWSR1 SRBD1 DNAJC7 PHB1 BPTF MSH6 GTF2I SPATS2L NOP14 P4HB MKI67 SUGP1 RBM5 ISG20L2 HADHA EIF3C PLEC TOP1 TOP2B | 5.89e-13 | 989 | 146 | 25 | 36424410 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ELOA MYH10 WAPL BCLAF1 U2AF2 YTHDC2 EWSR1 BPTF MSH6 GTF2I MKI67 SUGP1 RPRD2 TOP1 TOP2B | 1.28e-12 | 283 | 146 | 15 | 30585729 |
| Pubmed | ATP5F1E SMG1 ELOA MYH3 MYH8 MYH10 MYH11 CETN2 BCLAF1 U2AF2 ATP6V1G1 YBX3 SRBD1 RRBP1 ARID1A DNAJC7 CEP128 LYST PHB1 BPTF NOP14 P4HB RBM5 ISG20L2 HADHA PLEC RIMS2 TOP1 TOP2B | 1.92e-12 | 1442 | 146 | 29 | 35575683 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ELOA MYH10 BCLAF1 CAMK2D U2AF2 YTHDC2 EWSR1 YBX3 ITPRID2 SRBD1 RRBP1 EIF3CL LGALS8 PHB1 KIAA1671 MSH6 GTF2I SPATS2L NOP14 P4HB MKI67 AP1M1 HADHA PLEC FSCN1 TOP1 MARCKS | 2.78e-12 | 1257 | 146 | 27 | 36526897 |
| Pubmed | MYH10 POLE U2AF2 YTHDC2 EWSR1 ARID1A BIRC6 BPTF MSH6 GTF2I NOP14 P4HB MCM3AP MKI67 GIGYF2 HADHA PLEC FSCN1 TOP1 STOML2 | 5.00e-12 | 653 | 146 | 20 | 22586326 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | WAPL U2AF2 RRBP1 EIF3CL BPTF MSH6 ESYT2 GTF2I MKI67 RPRD2 HADHA EIF3C PLEC TOP2B | 1.05e-11 | 271 | 146 | 14 | 32433965 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ELOA WAPL BCLAF1 MATK YTHDC2 YBX3 ITPRID2 RRBP1 EIF3CL BPTF MSH6 ESYT2 GTF2I UBN1 NAF1 MKI67 GIGYF2 EIF3C PLEC DHX29 TOP2B | 1.36e-11 | 774 | 146 | 21 | 15302935 |
| Pubmed | MYH10 BCLAF1 CAMK2A CAMK2D ANXA8L1 ADGRB1 DGKG ATP6V1G1 ANXA8 RRBP1 BIRC6 EIF3CL PHB1 ESYT2 P4HB NAV3 AP1M1 HADHA EIF3C PLEC DHX29 MARCKS SOD2 STOML2 | 7.77e-11 | 1139 | 146 | 24 | 36417873 | |
| Pubmed | ELOA MYH10 ITPRID2 ARID1A DNAJC7 BIRC6 KIAA0753 KIAA1671 MSH6 TDRD3 ESYT2 PPP2R3A NOP14 TIAM1 HAUS1 VPS33B P4HB CEP135 MKI67 HADHA EIF3C STOML2 TTC33 | 9.29e-11 | 1049 | 146 | 23 | 27880917 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ZWILCH WAPL CENPE CETN2 BCLAF1 ANXA8L1 HJURP ANXA8 RRBP1 ARID1A EIF3CL PHB1 PPP2R1B GTF2I HAUS1 P4HB CEP135 MKI67 HADHA EIF3C FSCN1 TOP2B ANAPC4 TTC33 | 1.03e-10 | 1155 | 146 | 24 | 20360068 |
| Pubmed | ATP5F1E MYH8 MYH11 CASQ2 FIS1 RRBP1 CPT2 PHB1 FSIP2 HADHA PLEC CPLANE1 ATP5F1EP2 SOD2 | 1.48e-10 | 331 | 146 | 14 | 29199018 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH10 WAPL BCLAF1 POLE U2AF2 YTHDC2 YBX3 RRBP1 DNAJC7 EIF3CL PHB1 MSH6 GTF2I VPS33B P4HB MKI67 RBM5 GIGYF2 AP1M1 HADHA EIF3C DHX29 TOP1 MARCKS TOP2B STOML2 | 2.58e-10 | 1425 | 146 | 26 | 30948266 |
| Pubmed | 2.98e-10 | 4 | 146 | 4 | 12631290 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ELOA MYH10 WAPL BCLAF1 YTHDC2 RRBP1 KIAA1671 MSH6 TDRD3 GTF2I NAF1 MKI67 SUGP1 GIGYF2 RPRD2 EIF3C DHX29 TOP1 MARCKS TOP2B ANAPC4 | 4.22e-10 | 934 | 146 | 21 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ELOA WAPL BCLAF1 RTF2 U2AF2 EWSR1 YBX3 CBX4 RRBP1 ARID1A PHB1 BPTF GTF2I UBN1 MKI67 SUGP1 GIGYF2 RPRD2 TOP1 TOP2B ANAPC4 | 6.16e-10 | 954 | 146 | 21 | 36373674 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 WAPL BCLAF1 YTHDC2 RRBP1 ARID1A ZBTB1 MSH6 PPP2R1B GTF2I MKI67 RPRD2 DHX29 TOP2B ANAPC4 | 6.30e-10 | 440 | 146 | 15 | 34244565 |
| Pubmed | MYH3 MYH10 CAMK2D MXRA8 U2AF2 RRBP1 ARID1A EIF3CL PHB1 P4HB EIF3C PLEC | 1.15e-09 | 259 | 146 | 12 | 31162944 | |
| Pubmed | SMG1 MYH10 EWSR1 YBX3 BCL11A ARID1A DNAJC7 ZBTB1 PHB1 KIAA1671 BPTF GTF2I NOP14 UBN1 P4HB MKI67 SUGP1 GIGYF2 SMARCD3 RPRD2 HADHA EIF3C TOP1 LRIF1 SORD | 1.41e-09 | 1429 | 146 | 25 | 35140242 | |
| Pubmed | 1.49e-09 | 5 | 146 | 4 | 11836246 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 1.49e-09 | 5 | 146 | 4 | 19193628 | |
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 1.49e-09 | 5 | 146 | 4 | 22079585 | |
| Pubmed | 1.64e-09 | 116 | 146 | 9 | 21282530 | ||
| Pubmed | MYH10 CETN2 YBX3 ITPRID2 RRBP1 ARID1A DNAJC7 KIAA1671 MSH6 RIN2 MKI67 AP1M1 SMARCD3 HADHA FSCN1 TOP2B ANAPC4 | 1.65e-09 | 634 | 146 | 17 | 34591612 | |
| Pubmed | MYH10 BCLAF1 YTHDC2 EWSR1 YBX3 SRBD1 RRBP1 DNAJC7 PHB1 GTF2I P4HB RBM5 GIGYF2 EIF3C PLEC TOP1 | 1.66e-09 | 551 | 146 | 16 | 34728620 | |
| Pubmed | MYH10 BCLAF1 U2AF2 EWSR1 PHB1 MEMO1 MSH6 GTF2I NOP14 MKI67 GIGYF2 AP1M1 EIF3C FSCN1 TOP1 TOP2B STOML2 | 1.95e-09 | 641 | 146 | 17 | 36057605 | |
| Pubmed | DNAJC7 BIRC6 EIF3CL BPTF RNF220 MKI67 RBM5 GIGYF2 EIF3C PLEC FSCN1 DHX29 TOP1 | 1.96e-09 | 335 | 146 | 13 | 15741177 | |
| Pubmed | MYH10 BCLAF1 EWSR1 ITPRID2 RRBP1 GTF2I NOP14 RBM5 GIGYF2 HADHA PLEC TOP1 | 2.17e-09 | 274 | 146 | 12 | 34244482 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | MYH10 WAPL BCLAF1 CBX4 SRBD1 ARID1A BPTF NOP14 MCM3AP MKI67 EIF3C TOP1 TOP2B | 2.43e-09 | 341 | 146 | 13 | 32971831 |
| Pubmed | ELOA MYH10 MYH11 CETN2 BCLAF1 U2AF2 ATP6V1G1 EWSR1 YBX3 RRBP1 LGALS8 ADH1B GTF2I SPATS2L P4HB NAF1 MCM3AP MKI67 RBM5 ISG20L2 HADHA PLEC TOP1 MARCKS | 3.10e-09 | 1371 | 146 | 24 | 36244648 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP5F1E MYH10 MYH11 MYO7A BCLAF1 CAMK2D ATP6V1G1 YBX3 ARID1A DNAJC7 PHB1 MSH6 GTF2I AP1M1 SMARCD3 EIF3C PLEC DHX29 TOP1 | 3.20e-09 | 847 | 146 | 19 | 35235311 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | CAMK2D YTHDC2 BCL11A DNAJC7 MSH6 GTF2I SPATS2L NOP14 UBN1 MKI67 ISG20L2 EIF3C FSCN1 | 3.20e-09 | 349 | 146 | 13 | 25665578 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ELOA CENPE POLE HJURP YTHDC2 YBX3 SRBD1 RRBP1 BIRC6 BPTF MSH6 TDRD3 NOP14 MKI67 ISG20L2 DHX29 TOP1 TOP2B | 3.63e-09 | 759 | 146 | 18 | 35915203 |
| Pubmed | 4.44e-09 | 6 | 146 | 4 | 17257171 | ||
| Pubmed | 4.44e-09 | 6 | 146 | 4 | 12027900 | ||
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 4.44e-09 | 6 | 146 | 4 | 16121213 | |
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 4.44e-09 | 6 | 146 | 4 | 9982 | |
| Pubmed | 4.44e-09 | 6 | 146 | 4 | 518534 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ELOA MYH10 BCLAF1 U2AF2 EWSR1 CBX4 ARID1A PHB1 BPTF MSH6 NOP14 P4HB SUGP1 RBM5 SMARCD3 HADHA EIF3C PLEC TOP1 MARCKS TOP2B | 5.69e-09 | 1082 | 146 | 21 | 38697112 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ELOA MYH10 BCLAF1 U2AF2 EWSR1 BCL11A ARID1A PHB1 MSH6 GTF2I NOP14 MKI67 RBM5 EIF3C TOP1 TOP2B | 6.23e-09 | 605 | 146 | 16 | 28977666 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | BCLAF1 CAMK2D CBX4 ARID1A BPTF MSH6 TDRD3 NOP14 SUGP1 RBM5 ISG20L2 PLEC TOP1 | 6.44e-09 | 370 | 146 | 13 | 22922362 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | POLE RTF2 U2AF2 YTHDC2 BIRC6 MEMO1 MSH6 VPS33B AP1M1 HADHA EIF3C FSCN1 DHX29 TOP1 TOP2B STOML2 SORD | 7.81e-09 | 704 | 146 | 17 | 29955894 |
| Pubmed | U2AF2 YTHDC2 EWSR1 YBX3 SRBD1 RRBP1 ARID1A PHB1 SPATS2L TULP4 GIGYF2 HADHA EIF3C DHX29 TOP1 TOP2B | 7.85e-09 | 615 | 146 | 16 | 31048545 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SMG1 BCLAF1 U2AF2 YTHDC2 EWSR1 YBX3 RRBP1 TDRD3 SPATS2L NOP14 P4HB NAF1 SUGP1 RBM5 GIGYF2 EIF3C DHX29 TOP1 | 9.36e-09 | 807 | 146 | 18 | 22681889 |
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 23456092 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 1.03e-08 | 7 | 146 | 4 | 23468174 | |
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 16047160 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 11784316 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 37953328 | ||
| Pubmed | ELOA WAPL CETN2 BCLAF1 POLE RTF2 CBX4 RRBP1 DNAJC7 PHB1 BPTF MSH6 GTF2I UBN1 MKI67 PLEC FSCN1 TOP1 TOP2B SORD | 1.04e-08 | 1014 | 146 | 20 | 32416067 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ATP5F1E MYH10 CENPE POLE U2AF2 YTHDC2 FIS1 YBX3 ITPRID2 RRBP1 CPT2 DNAJC7 BIRC6 PHB1 KIAA1671 TDRD3 ESYT2 SPATS2L NOP14 VPS33B ISG20L2 HADHA TOP1 STOML2 | 1.66e-08 | 1496 | 146 | 24 | 32877691 |
| Pubmed | 2.06e-08 | 8 | 146 | 4 | 18331377 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH10 RTF2 U2AF2 EWSR1 YBX3 RRBP1 DNAJC7 BIRC6 PHB1 MEMO1 MSH6 GTF2I P4HB NAF1 GIGYF2 AP1M1 HADHA EIF3C PLEC FSCN1 TOP1 MARCKS TOP2B | 2.70e-08 | 1415 | 146 | 23 | 28515276 |
| Pubmed | 3.69e-08 | 9 | 146 | 4 | 11747070 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ELOA WAPL CBX4 SRBD1 FSIP2 BPTF MSH6 RNF220 GTF2I NOP14 UBN1 MKI67 TOP1 LRIF1 TOP2B | 4.74e-08 | 608 | 146 | 15 | 36089195 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATP5F1E SMG1 MYH3 MYH8 BCLAF1 CAMK2D FIS1 RRBP1 LYST EIF3CL RIN2 EIF3C PLEC UBASH3B CPLANE1 MARCKS ATP5F1EP2 ANAPC4 | 5.77e-08 | 910 | 146 | 18 | 36736316 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | BCLAF1 U2AF2 YTHDC2 EWSR1 ITPRID2 RRBP1 DNAJC7 PHB1 KIAA1671 BPTF P4HB MKI67 GIGYF2 HADHA EIF3C PLEC TOP1 TOP2B STOML2 | 6.53e-08 | 1024 | 146 | 19 | 24711643 |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 11960985 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 2474823 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 2737681 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 7.25e-08 | 3 | 146 | 3 | 23772048 | |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 8163197 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 7.25e-08 | 3 | 146 | 3 | 24787690 | |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 24143248 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 3011597 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 6756216 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 37806378 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 7840644 | ||
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 7.25e-08 | 3 | 146 | 3 | 15670660 | |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 8018987 | ||
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 7.25e-08 | 3 | 146 | 3 | 33586683 | |
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 7.25e-08 | 3 | 146 | 3 | 3157987 | |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 2169444 | ||
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 7.25e-08 | 3 | 146 | 3 | 8486690 | |
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 7.25e-08 | 3 | 146 | 3 | 16801720 | |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 7.25e-08 | 3 | 146 | 3 | 10424757 | |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 2347582 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 7.25e-08 | 3 | 146 | 3 | 7748347 | |
| Pubmed | Polymorphism in ADH and MTHFR genes in oral squamous cell carcinoma of Indians. | 7.25e-08 | 3 | 146 | 3 | 18266839 | |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 3006456 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 7.25e-08 | 3 | 146 | 3 | 9145544 | |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 7.25e-08 | 3 | 146 | 3 | 6816803 | |
| Pubmed | Alcohol dehydrogenase polymorphisms influence alcohol-elimination rates in a male Jewish population. | 7.25e-08 | 3 | 146 | 3 | 14745297 | |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 7.25e-08 | 3 | 146 | 3 | 15554233 | |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 35354963 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 6370228 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 2935875 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CETN2 BCLAF1 CAMK2D U2AF2 YTHDC2 YBX3 RRBP1 TDRD3 SPATS2L MKI67 GIGYF2 HADHA PLEC DHX29 TOP1 TOP2B | 7.47e-08 | 724 | 146 | 16 | 36232890 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | ELOA SPTB HJURP YTHDC2 ANXA8 ITPRID2 RYR1 KIAA1671 ESYT2 SPATS2L P4HB NAV3 RBM5 TEKT1 LUM CPLANE1 | 8.67e-08 | 732 | 146 | 16 | 34732716 |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 1.11e-07 | 90 | 146 | 7 | 35654790 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CETN2 BCLAF1 U2AF2 EWSR1 CBX4 SRBD1 RRBP1 ARID1A PHB1 BPTF ESYT2 GTF2I UBN1 MKI67 RBM5 RPRD2 ISG20L2 HADHA TOP1 LRIF1 TOP2B | 1.19e-07 | 1294 | 146 | 21 | 30804502 |
| Pubmed | SMG1 U2AF2 YTHDC2 YBX3 RRBP1 DNAJC7 EIF3CL PHB1 MSH6 NOP14 NAF1 HADHA DHX29 TOP1 GPRASP2 MARCKS STOML2 ANAPC4 | 1.51e-07 | 971 | 146 | 18 | 33306668 | |
| Pubmed | SMG1 MYH3 MYH8 COL12A1 SPTB BIRC6 RYR1 P4HB MED12L RBM5 EIF3C PLEC PLCE1 | 2.00e-07 | 497 | 146 | 13 | 23414517 | |
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 8813054 | ||
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 2893758 | ||
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 11893554 | ||
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 29663519 | ||
| Interaction | ECT2 interactions | ELOA MYH10 MYH11 BCLAF1 SPTB U2AF2 YBX3 ARID1A LYST EIF3CL PHB1 KIAA1671 ESYT2 GTF2I P4HB CEP135 MKI67 NAV3 GIGYF2 HADHA PLEC TOP1 TOP2B STOML2 | 1.57e-08 | 887 | 143 | 24 | int:ECT2 |
| Interaction | BMI1 interactions | BCLAF1 HSF2BP EWSR1 YBX3 CBX4 GCNT2 RRBP1 EIF3CL SPATS2L NOP14 P4HB MAPKAPK3 MKI67 SUGP1 GIGYF2 EIF3C PLEC DHX29 LRIF1 | 2.20e-07 | 659 | 143 | 19 | int:BMI1 |
| Interaction | SIRT7 interactions | MYH10 POLE U2AF2 YTHDC2 EWSR1 ARID1A BIRC6 BPTF MSH6 GTF2I NOP14 P4HB MCM3AP MKI67 GIGYF2 HADHA PLEC FSCN1 TOP1 STOML2 | 3.13e-07 | 744 | 143 | 20 | int:SIRT7 |
| Interaction | ADARB1 interactions | WAPL U2AF2 YTHDC2 YBX3 RRBP1 EIF3CL BPTF ESYT2 GTF2I SPATS2L MKI67 RPRD2 HADHA EIF3C PLEC TOP2B | 4.08e-07 | 489 | 143 | 16 | int:ADARB1 |
| Interaction | SOX2 interactions | ELOA CETN2 BCLAF1 SPTB HJURP YTHDC2 ANXA8 EWSR1 CBX4 ITPRID2 ARID1A LIN28A RYR1 KIAA1671 BPTF MSH6 ESYT2 GTF2I SPATS2L P4HB NAV3 RBM5 TEKT1 HADHA LUM CPLANE1 TOP1 ANAPC4 | 6.94e-07 | 1422 | 143 | 28 | int:SOX2 |
| Interaction | IFI16 interactions | ELOA CAMK2D U2AF2 YTHDC2 YBX3 ITPRID2 SRBD1 PHB1 MSH6 SPATS2L NOP14 B3GNT2 MCM3AP MKI67 ISG20L2 EIF3C DHX29 TOP1 TOP2B | 7.41e-07 | 714 | 143 | 19 | int:IFI16 |
| Interaction | CHD4 interactions | ELOA MYH10 BCLAF1 U2AF2 EWSR1 BCL11A RRBP1 ARID1A BIRC6 PHB1 BPTF MSH6 GTF2I NOP14 MKI67 RBM5 GIGYF2 EIF3C UBASH3B TOP1 LRIF1 TOP2B | 7.70e-07 | 938 | 143 | 22 | int:CHD4 |
| Interaction | NAA40 interactions | ELOA MYH10 WAPL CETN2 BCLAF1 YTHDC2 RRBP1 KIAA1671 MSH6 TDRD3 GTF2I NAF1 MKI67 SUGP1 GIGYF2 RPRD2 EIF3C DHX29 TOP1 MARCKS TOP2B ANAPC4 | 1.54e-06 | 978 | 143 | 22 | int:NAA40 |
| Interaction | PARP1 interactions | ELOA MYH10 CETN2 POLE U2AF2 YTHDC2 EWSR1 YBX3 CBX4 BCL11A ITPRID2 SRBD1 CPT2 PHB1 BPTF MSH6 NOP14 B3GNT2 MKI67 CYP4F12 HADHA EIF3C FSCN1 TOP1 LRIF1 TOP2B | 1.75e-06 | 1316 | 143 | 26 | int:PARP1 |
| Interaction | CHD3 interactions | ELOA MYH10 BCLAF1 HJURP U2AF2 EWSR1 CBX4 BCL11A ARID1A PHB1 BPTF MSH6 GTF2I MKI67 RBM5 EIF3C TOP1 LRIF1 TOP2B | 1.76e-06 | 757 | 143 | 19 | int:CHD3 |
| Interaction | TBC1D31 interactions | 2.79e-06 | 56 | 143 | 6 | int:TBC1D31 | |
| Interaction | SMG7 interactions | SMG1 U2AF2 YBX3 ARID1A CEP128 KIAA0753 TDRD3 NOP14 VPS33B CEP135 RBM5 RPRD2 | 3.00e-06 | 319 | 143 | 12 | int:SMG7 |
| Interaction | GLDC interactions | MYH10 BCLAF1 EWSR1 ITPRID2 RRBP1 GTF2I NOP14 RBM5 GIGYF2 HADHA PLEC TOP1 | 3.20e-06 | 321 | 143 | 12 | int:GLDC |
| Interaction | ACE2 interactions | MYH10 BCLAF1 SPTB U2AF2 EWSR1 YBX3 PHB1 MEMO1 MSH6 GTF2I NOP14 MKI67 GIGYF2 AP1M1 HADHA EIF3C PLEC FSCN1 TOP1 MARCKS TOP2B STOML2 SORD | 3.25e-06 | 1106 | 143 | 23 | int:ACE2 |
| Interaction | HDAC1 interactions | MYH8 MYH10 U2AF2 BCL11A ARID1A CEP128 BIRC6 ZBTB1 PHB1 KIAA1671 BPTF MSH6 PPP2R1B GTF2I CEP135 MKI67 GIGYF2 EIF3C PLEC UBASH3B FSCN1 GPRASP2 TOP2B | 3.35e-06 | 1108 | 143 | 23 | int:HDAC1 |
| Interaction | BARD1 interactions | ELOA BCLAF1 HSF2BP U2AF2 EWSR1 LGALS8 MSH6 MKI67 TOP1 LRIF1 GPRASP2 TOP2B | 3.42e-06 | 323 | 143 | 12 | int:BARD1 |
| Interaction | MECP2 interactions | ELOA MYH10 BCLAF1 CAMK2A CAMK2D U2AF2 EWSR1 CBX4 SRBD1 ARID1A PHB1 BPTF MSH6 NOP14 P4HB MKI67 SUGP1 RBM5 SMARCD3 HADHA EIF3C PLEC TOP1 MARCKS TOP2B | 3.86e-06 | 1287 | 143 | 25 | int:MECP2 |
| Interaction | PSPC1 interactions | U2AF2 YTHDC2 EWSR1 YBX3 CBX4 RRBP1 PHB1 SPATS2L P4HB ISG20L2 EIF3C DHX29 TOP1 LRIF1 TOP2B | 4.02e-06 | 515 | 143 | 15 | int:PSPC1 |
| Interaction | NINL interactions | ELOA CENPE CAMK2A CAMK2D EWSR1 CEP128 KIAA0753 PHB1 KIAA1671 TDRD3 HAUS1 VPS33B GIGYF2 RPRD2 | 4.95e-06 | 458 | 143 | 14 | int:NINL |
| Interaction | KIF20A interactions | MYH10 MYH11 CENPE BCLAF1 SPTB APC2 U2AF2 YBX3 ITPRID2 PHB1 KIAA1671 P4HB CEP135 MKI67 NAV3 GIGYF2 HADHA PLEC UBASH3B TOP1 TOP2B STOML2 | 5.00e-06 | 1052 | 143 | 22 | int:KIF20A |
| Interaction | H3C1 interactions | ELOA MYH10 WAPL CAMK2A RTF2 CBX4 SRBD1 RRBP1 DNAJC7 BPTF MSH6 SPATS2L UBN1 MKI67 NAV3 HADHA EIF3C TOP1 LRIF1 TOP2B | 5.90e-06 | 901 | 143 | 20 | int:H3C1 |
| Interaction | USP53 interactions | 6.44e-06 | 138 | 143 | 8 | int:USP53 | |
| Interaction | ABTB2 interactions | 7.71e-06 | 101 | 143 | 7 | int:ABTB2 | |
| Interaction | SMC5 interactions | ELOA WAPL BCLAF1 RTF2 U2AF2 EWSR1 YBX3 CBX4 RRBP1 ARID1A PHB1 BPTF GTF2I UBN1 MKI67 SUGP1 GIGYF2 RPRD2 TOP1 TOP2B ANAPC4 | 7.90e-06 | 1000 | 143 | 21 | int:SMC5 |
| Interaction | NIN interactions | CENPE CAMK2D CASQ2 CEP128 KIAA1671 ESYT2 PPP2R3A HAUS1 VPS33B CEP135 GIGYF2 CPLANE1 | 9.98e-06 | 359 | 143 | 12 | int:NIN |
| Interaction | TRIM37 interactions | ELOA MYH10 U2AF2 EWSR1 ITPRID2 CEP128 KIAA0753 PHB1 UBN1 P4HB MCM3AP MKI67 GIGYF2 RPRD2 PLEC FSCN1 | 1.06e-05 | 630 | 143 | 16 | int:TRIM37 |
| Interaction | H3C3 interactions | ELOA WAPL CBX4 SRBD1 FSIP2 BPTF MSH6 RNF220 GTF2I NOP14 MKI67 TOP1 LRIF1 TOP2B | 1.19e-05 | 495 | 143 | 14 | int:H3C3 |
| Interaction | RPS19 interactions | HJURP YTHDC2 EWSR1 YBX3 CBX4 RRBP1 LIN28A PHB1 BPTF SPATS2L NOP14 B3GNT2 SUGP1 RBM5 HADHA TOP1 | 1.27e-05 | 639 | 143 | 16 | int:RPS19 |
| Interaction | FOXP3 interactions | BCLAF1 CAMK2D CBX4 ARID1A BPTF MSH6 TDRD3 NOP14 SUGP1 RBM5 ISG20L2 PLEC TOP1 | 1.29e-05 | 432 | 143 | 13 | int:FOXP3 |
| Interaction | HNRNPU interactions | MYH10 BCLAF1 U2AF2 YTHDC2 EWSR1 YBX3 SRBD1 BIRC6 KIAA0753 PHB1 SPATS2L P4HB B3GNT2 HADHA EIF3C UBASH3B CPLANE1 DHX29 TOP1 MARCKS TTC33 | 1.33e-05 | 1035 | 143 | 21 | int:HNRNPU |
| Interaction | RPS6 interactions | ELOA YTHDC2 YBX3 RRBP1 EIF3CL PHB1 TDRD3 SPATS2L NOP14 GVINP1 VPS33B P4HB B3GNT2 MKI67 ISG20L2 HADHA DHX29 TOP1 TOP2B | 1.38e-05 | 874 | 143 | 19 | int:RPS6 |
| Interaction | SUZ12 interactions | BCLAF1 U2AF2 EWSR1 YBX3 BCL11A BIRC6 PHB1 BPTF GTF2I P4HB MKI67 RBM5 PLEC FSCN1 TOP1 STOML2 | 1.40e-05 | 644 | 143 | 16 | int:SUZ12 |
| Interaction | NDC80 interactions | ZWILCH CENPE DNAJC7 CEP128 BIRC6 KIAA0753 KIAA1671 GTF2I HAUS1 CEP135 TOP1 | 1.45e-05 | 312 | 143 | 11 | int:NDC80 |
| Interaction | POU5F1 interactions | WAPL CETN2 EWSR1 ARID1A BPTF MSH6 PPP2R3A GTF2I SUGP1 GIGYF2 HADHA DHX29 TOP1 TOP2B ANAPC4 | 1.79e-05 | 584 | 143 | 15 | int:POU5F1 |
| Interaction | CHAF1A interactions | ELOA EWSR1 BCL11A ARID1A BPTF MSH6 GTF2I CEP135 EIF3C LRIF1 TOP2B | 1.94e-05 | 322 | 143 | 11 | int:CHAF1A |
| Interaction | BRCA2 interactions | SMG1 POLE HSF2BP EWSR1 ARID1A DNAJC7 GPR179 CEP135 MKI67 RPRD2 PLEC TOP1 | 1.95e-05 | 384 | 143 | 12 | int:BRCA2 |
| Interaction | ZBTB2 interactions | BCLAF1 CAMK2D RTF2 YBX3 BCL11A ZBTB1 PHB1 MSH6 NOP14 P4HB TOP1 MARCKS TOP2B | 1.99e-05 | 450 | 143 | 13 | int:ZBTB2 |
| Interaction | TARDBP interactions | BCLAF1 U2AF2 YTHDC2 EWSR1 YBX3 SRBD1 RRBP1 PHB1 RNF220 NOP14 GIGYF2 AP1M1 EIF3C TOP1 | 2.06e-05 | 520 | 143 | 14 | int:TARDBP |
| Interaction | HECTD1 interactions | ELOA MYH10 CENPE POLE HJURP U2AF2 YTHDC2 YBX3 SRBD1 RRBP1 BIRC6 BPTF MSH6 TDRD3 NOP14 MKI67 ISG20L2 DHX29 TOP1 TOP2B | 2.13e-05 | 984 | 143 | 20 | int:HECTD1 |
| Interaction | H3-3A interactions | ELOA WAPL CAMK2A U2AF2 CBX4 SRBD1 BPTF MSH6 RNF220 GTF2I NOP14 UBN1 TIAM1 MKI67 TOP1 LRIF1 TOP2B | 2.37e-05 | 749 | 143 | 17 | int:H3-3A |
| Interaction | PRMT1 interactions | MYH10 BCLAF1 U2AF2 YTHDC2 EWSR1 YBX3 SRBD1 RRBP1 DNAJC7 PHB1 TDRD3 GTF2I P4HB RBM5 GIGYF2 EIF3C PLEC TOP1 LRIF1 | 3.20e-05 | 929 | 143 | 19 | int:PRMT1 |
| Interaction | HAUS2 interactions | 3.27e-05 | 126 | 143 | 7 | int:HAUS2 | |
| Interaction | NUP43 interactions | CETN2 BCLAF1 ITPRID2 ARID1A FSIP2 BPTF RNF220 GTF2I NOP14 MCM3AP MKI67 FSCN1 TOP1 TOP2B ANAPC4 | 3.91e-05 | 625 | 143 | 15 | int:NUP43 |
| Interaction | SRRM1 interactions | ELOA WAPL CETN2 BCLAF1 U2AF2 EWSR1 YBX3 LIN28A GTF2I TOP1 TOP2B | 3.95e-05 | 348 | 143 | 11 | int:SRRM1 |
| Interaction | MEN1 interactions | MYH10 WAPL CETN2 BCLAF1 U2AF2 EWSR1 YBX3 CBX4 SRBD1 ARID1A BPTF GTF2I NOP14 MCM3AP MKI67 RBM5 GIGYF2 EIF3C TOP1 TOP2B | 4.01e-05 | 1029 | 143 | 20 | int:MEN1 |
| Interaction | SIRT6 interactions | SMG1 WAPL BCLAF1 YTHDC2 RRBP1 ARID1A ZBTB1 MSH6 PPP2R1B GTF2I MKI67 RPRD2 DHX29 TOP2B ANAPC4 | 4.13e-05 | 628 | 143 | 15 | int:SIRT6 |
| Interaction | PRPF3 interactions | ELOA HSF2BP U2AF2 CASQ2 LIN28A PHB1 MKI67 DHX29 TOP1 GPRASP2 | 4.45e-05 | 291 | 143 | 10 | int:PRPF3 |
| Interaction | BRD7 interactions | BCLAF1 U2AF2 YTHDC2 EWSR1 YBX3 RRBP1 ARID1A DNAJC7 NAF1 MKI67 SMARCD3 HADHA TOP1 LRIF1 GPRASP2 | 4.86e-05 | 637 | 143 | 15 | int:BRD7 |
| Interaction | FBL interactions | ELOA CAMK2A U2AF2 YTHDC2 RRBP1 LIN28A TDRD3 SPATS2L NOP14 NAF1 MKI67 FSCN1 DHX29 TOP1 TOP2B | 5.03e-05 | 639 | 143 | 15 | int:FBL |
| Interaction | CSNK2A2 interactions | ELOA CLUAP1 BCLAF1 CASQ2 YBX3 CBX4 LYST EIF3CL ADH1A P4HB MKI67 RBM5 AP1M1 HADHA EIF3C TOP1 | 5.19e-05 | 718 | 143 | 16 | int:CSNK2A2 |
| Interaction | POC5 interactions | 5.94e-05 | 95 | 143 | 6 | int:POC5 | |
| Interaction | PRC1 interactions | MYH10 CENPE BCLAF1 SPTB HSF2BP U2AF2 YBX3 ARID1A PHB1 KIAA1671 PPP2R1B P4HB MKI67 HADHA PLEC DHX29 TOP1 TOP2B STOML2 | 5.97e-05 | 973 | 143 | 19 | int:PRC1 |
| Interaction | H2BC8 interactions | ELOA WAPL CETN2 CBX4 SRBD1 BPTF MSH6 GTF2I NOP14 MKI67 SUGP1 TOP1 LRIF1 TOP2B | 6.27e-05 | 576 | 143 | 14 | int:H2BC8 |
| Interaction | CCDC8 interactions | CASQ2 YTHDC2 EWSR1 ITPRID2 PHB1 KIAA1671 P4HB MKI67 GIGYF2 HADHA EIF3C PLEC GPRASP2 MARCKS STOML2 | 6.76e-05 | 656 | 143 | 15 | int:CCDC8 |
| Interaction | H1-4 interactions | CETN2 CAMK2A YTHDC2 YBX3 DNAJC7 LIN28A PHB1 SPATS2L NOP14 B3GNT2 MTHFD2L GIGYF2 ISG20L2 UBASH3B TOP2B | 6.76e-05 | 656 | 143 | 15 | int:H1-4 |
| Interaction | CCDC15 interactions | 7.34e-05 | 12 | 143 | 3 | int:CCDC15 | |
| Interaction | CIT interactions | MYH10 MYH11 BCLAF1 SPTB U2AF2 YTHDC2 SRBD1 BIRC6 EIF3CL PHB1 KIAA1671 BPTF MSH6 GTF2I NOP14 P4HB MKI67 RBM5 CYP4F12 HADHA PLEC FSCN1 TOP1 TOP2B | 8.33e-05 | 1450 | 143 | 24 | int:CIT |
| Interaction | WDR76 interactions | MYH10 CETN2 CAMK2A CAMK2D MSH6 GTF2I P4HB MKI67 HADHA PLEC TOP1 | 9.31e-05 | 383 | 143 | 11 | int:WDR76 |
| Interaction | ADH1B interactions | 9.50e-05 | 13 | 143 | 3 | int:ADH1B | |
| Interaction | SNRPF interactions | COL12A1 BCLAF1 U2AF2 EWSR1 LIN28A PHB1 P4HB SUGP1 RPRD2 TOP1 TTC33 | 9.75e-05 | 385 | 143 | 11 | int:SNRPF |
| Interaction | WWP2 interactions | U2AF2 YTHDC2 EWSR1 YBX3 SRBD1 RRBP1 ARID1A PHB1 SPATS2L TULP4 GIGYF2 SMARCD3 HADHA EIF3C DHX29 TOP1 TOP2B | 9.79e-05 | 840 | 143 | 17 | int:WWP2 |
| Interaction | RPL31 interactions | ELOA BCLAF1 YTHDC2 EWSR1 YBX3 RRBP1 LIN28A PHB1 SPATS2L NOP14 B3GNT2 MKI67 ISG20L2 TOP1 TOP2B | 1.01e-04 | 680 | 143 | 15 | int:RPL31 |
| Interaction | LRRC59 interactions | MYH8 MYH11 U2AF2 EWSR1 YBX3 ITPRID2 RRBP1 PHB1 MSH6 ESYT2 SPATS2L P4HB GIGYF2 EIF3C DHX29 TOP1 MARCKS | 1.05e-04 | 845 | 143 | 17 | int:LRRC59 |
| Interaction | CUL7 interactions | BCLAF1 DGKG U2AF2 CASQ2 EWSR1 RRBP1 DNAJC7 PHB1 BPTF MSH6 P4HB MKI67 HADHA PLEC TOP1 TOP2B STOML2 | 1.05e-04 | 845 | 143 | 17 | int:CUL7 |
| Interaction | CEP120 interactions | 1.09e-04 | 106 | 143 | 6 | int:CEP120 | |
| Interaction | LRRC31 interactions | 1.10e-04 | 205 | 143 | 8 | int:LRRC31 | |
| Interaction | SMAD9 interactions | 1.12e-04 | 153 | 143 | 7 | int:SMAD9 | |
| Interaction | PLK4 interactions | 1.16e-04 | 154 | 143 | 7 | int:PLK4 | |
| Interaction | DCPS interactions | MYH10 CEP128 CEP135 MKI67 AP1M1 RPRD2 PLEC TOP1 LRIF1 TOP2B ANAPC4 | 1.19e-04 | 394 | 143 | 11 | int:DCPS |
| Interaction | ACTC1 interactions | MYH10 BCLAF1 YBX3 BCL11A ARID1A PHB1 MSH6 GTF2I MKI67 SUGP1 SMARCD3 RPRD2 HADHA PLEC FSCN1 | 1.26e-04 | 694 | 143 | 15 | int:ACTC1 |
| Interaction | H2BC21 interactions | ZWILCH BCLAF1 CASQ2 CBX4 SRBD1 ARID1A BPTF MSH6 MKI67 RPRD2 FSCN1 TOP1 LRIF1 TOP2B ANAPC4 | 1.30e-04 | 696 | 143 | 15 | int:H2BC21 |
| Interaction | TOP1 interactions | BCLAF1 POLE U2AF2 CBX4 ARID1A PHB1 MSH6 PPP2R1B TIAM1 P4HB MKI67 RPRD2 DHX29 TOP1 TOP2B | 1.30e-04 | 696 | 143 | 15 | int:TOP1 |
| Interaction | KIAA0753 interactions | 1.31e-04 | 157 | 143 | 7 | int:KIAA0753 | |
| Interaction | DDX23 interactions | ELOA MYH10 BCLAF1 U2AF2 EWSR1 MSH6 NOP14 NAF1 SUGP1 RBM5 TOP1 TOP2B | 1.65e-04 | 480 | 143 | 12 | int:DDX23 |
| Interaction | BTF3 interactions | SMG1 MYH10 CETN2 BCLAF1 SPTB U2AF2 ITPRID2 RRBP1 LGALS8 GTF2I MKI67 HADHA EIF3C PLEC DHX29 TOP1 | 1.79e-04 | 799 | 143 | 16 | int:BTF3 |
| Interaction | SMNDC1 interactions | 1.80e-04 | 116 | 143 | 6 | int:SMNDC1 | |
| Interaction | TULP3 interactions | 1.85e-04 | 346 | 143 | 10 | int:TULP3 | |
| Interaction | CBX6 interactions | 1.93e-04 | 283 | 143 | 9 | int:CBX6 | |
| Interaction | BRCA1 interactions | CFAP47 ELOA MYH10 WAPL CAMK2D MATK POLE EWSR1 ITPRID2 ARID1A ZBTB1 BPTF MSH6 GTF2I P4HB MKI67 AP1M1 PLEC TOP1 TOP2B ANAPC4 | 1.97e-04 | 1249 | 143 | 21 | int:BRCA1 |
| Interaction | DDRGK1 interactions | ELOA MYH11 BCLAF1 U2AF2 YTHDC2 FIS1 EWSR1 YBX3 SRBD1 RRBP1 DNAJC7 EIF3CL PHB1 ESYT2 SPATS2L NOP14 RBM5 HADHA TOP1 MARCKS STOML2 | 1.97e-04 | 1249 | 143 | 21 | int:DDRGK1 |
| Interaction | DLST interactions | ELOA MYH11 RRBP1 DNAJC7 PHB1 BPTF PLEC FSCN1 TOP1 TOP2B SOD2 STOML2 | 1.99e-04 | 490 | 143 | 12 | int:DLST |
| Interaction | EED interactions | MYH10 MYH11 BCLAF1 HJURP U2AF2 CBX4 BCL11A ARID1A BIRC6 LIN28A PHB1 BPTF MSH6 GTF2I NOP14 B3GNT2 RBM5 AP1M1 ISG20L2 HADHA PLEC FSCN1 TOP1 | 2.12e-04 | 1445 | 143 | 23 | int:EED |
| Interaction | YWHAE interactions | ELOA MYH10 MYH11 CENPE HJURP U2AF2 EWSR1 CBX4 ITPRID2 LYST LGALS8 ADH1B PHB1 ADH4 KIAA1671 TIAM1 NAF1 GIGYF2 RIMS2 ARHGAP45 STOML2 | 2.13e-04 | 1256 | 143 | 21 | int:YWHAE |
| Interaction | SNRNP70 interactions | ELOA MYH10 BCLAF1 U2AF2 YTHDC2 EWSR1 YBX3 SRBD1 LIN28A PHB1 MSH6 NOP14 TIAM1 NAF1 MKI67 DHX29 TOP1 TOP2B | 2.13e-04 | 984 | 143 | 18 | int:SNRNP70 |
| Interaction | SSX2IP interactions | TRIM42 CEP128 KIAA0753 KIAA1671 TDRD3 HAUS1 VPS33B CEP135 AP1M1 | 2.20e-04 | 288 | 143 | 9 | int:SSX2IP |
| Interaction | FZR1 interactions | SMG1 MYH8 CAMK2A U2AF2 YTHDC2 YBX3 RRBP1 DNAJC7 EIF3CL PHB1 MSH6 NOP14 NAF1 HADHA DHX29 TOP1 GPRASP2 MARCKS STOML2 ANAPC4 | 2.34e-04 | 1172 | 143 | 20 | int:FZR1 |
| Interaction | MECOM interactions | 2.44e-04 | 358 | 143 | 10 | int:MECOM | |
| Interaction | SRSF6 interactions | BCLAF1 U2AF2 YTHDC2 EWSR1 YBX3 SRBD1 PHB1 BPTF NOP14 B3GNT2 MKI67 RBM5 | 2.53e-04 | 503 | 143 | 12 | int:SRSF6 |
| Interaction | YAP1 interactions | MYH10 MYH11 WAPL BCLAF1 APC2 RRBP1 ARID1A DNAJC7 PHB1 BPTF MSH6 GTF2I TULP4 P4HB GIGYF2 RPRD2 HADHA PLEC ARHGAP45 | 2.75e-04 | 1095 | 143 | 19 | int:YAP1 |
| Interaction | TRIM28 interactions | ELOA POLE RTF2 U2AF2 YTHDC2 BIRC6 ZBTB1 LIN28A PHB1 MEMO1 MSH6 VPS33B B3GNT2 MKI67 AP1M1 HADHA EIF3C FSCN1 DHX29 TOP1 TOP2B STOML2 SORD | 2.83e-04 | 1474 | 143 | 23 | int:TRIM28 |
| Interaction | CFTR interactions | CFAP47 MYH3 MYH8 MYH10 MYH11 POLE BDH2 CASQ2 EWSR1 RRBP1 PHB1 PPP2R1B ESYT2 GTF2I TIAM1 P4HB CYP4F12 PLEC LUM FSCN1 TOP1 MARCKS STOML2 | 2.99e-04 | 1480 | 143 | 23 | int:CFTR |
| Interaction | XRCC6 interactions | ELOA MYH10 WAPL BCLAF1 U2AF2 YTHDC2 EWSR1 PHB1 BPTF MSH6 GTF2I MKI67 SUGP1 RPRD2 TOP1 MARCKS TOP2B | 3.18e-04 | 928 | 143 | 17 | int:XRCC6 |
| Interaction | TPTE2 interactions | 3.30e-04 | 84 | 143 | 5 | int:TPTE2 | |
| Interaction | CENPA interactions | 3.67e-04 | 377 | 143 | 10 | int:CENPA | |
| Interaction | CDV3 interactions | 3.68e-04 | 86 | 143 | 5 | int:CDV3 | |
| Interaction | MED4 interactions | MYH11 CENPE BCLAF1 EWSR1 CEP128 KIAA0753 HAUS1 CEP135 MED12L RPRD2 HADHA | 3.75e-04 | 450 | 143 | 11 | int:MED4 |
| Interaction | KIF23 interactions | ZWILCH MYH10 MYH11 BCLAF1 U2AF2 YTHDC2 YBX3 BIRC6 MSH6 NOP14 P4HB CEP135 MKI67 HADHA PLEC TOP1 TOP2B STOML2 | 3.75e-04 | 1031 | 143 | 18 | int:KIF23 |
| Interaction | TNIP1 interactions | ELOA MYH10 MYH11 BCLAF1 U2AF2 EWSR1 YBX3 CBX4 ITPRID2 RRBP1 EIF3CL GTF2I VPS33B CEP135 MKI67 AP1M1 HADHA EIF3C PLEC TOP1 | 3.81e-04 | 1217 | 143 | 20 | int:TNIP1 |
| Interaction | CAPRIN1 interactions | MYH10 U2AF2 EIF3CL PHB1 MSH6 TDRD3 B3GNT2 MKI67 GIGYF2 DHX29 TOP2B | 3.82e-04 | 451 | 143 | 11 | int:CAPRIN1 |
| Interaction | RPS24 interactions | ELOA U2AF2 LIN28A EIF3CL PHB1 TDRD3 SPATS2L NOP14 B3GNT2 ISG20L2 EIF3C TOP2B | 3.99e-04 | 529 | 143 | 12 | int:RPS24 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 5.97e-06 | 37 | 146 | 4 | chr4q23 | |
| Cytoband | 4q23 | 3.45e-05 | 20 | 146 | 3 | 4q23 | |
| Cytoband | 17p13.1 | 5.69e-04 | 118 | 146 | 4 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 8.79e-04 | 346 | 146 | 6 | chr17p13 | |
| GeneFamily | Alcohol dehydrogenases | 6.06e-08 | 8 | 100 | 4 | 397 | |
| GeneFamily | Myosin heavy chains | 1.15e-06 | 15 | 100 | 4 | 1098 | |
| GeneFamily | Protein disulfide isomerases | 2.03e-04 | 21 | 100 | 3 | 692 | |
| GeneFamily | EF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2 | 3.00e-04 | 5 | 100 | 2 | 1276 | |
| GeneFamily | Topoisomerases | 4.48e-04 | 6 | 100 | 2 | 1050 | |
| GeneFamily | Annexins|Endogenous ligands | 2.27e-03 | 13 | 100 | 2 | 404 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.33e-03 | 181 | 100 | 5 | 694 | |
| Coexpression | GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP | GTF2I TIAM1 RIN2 B3GNT2 RBM5 ASB4 CYP4F12 ARHGAP45 GPRASP2 TOP2B | 1.92e-07 | 200 | 146 | 10 | M6369 |
| Coexpression | DESCARTES_ORGANOGENESIS_MYOCYTES | 8.16e-06 | 129 | 146 | 7 | MM3644 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN | CENPE U2AF2 EWSR1 DNAJC7 PHB1 MAPKAPK3 MKI67 TOP1 TOP2B SOD2 | 9.13e-06 | 307 | 146 | 10 | M19745 |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 1.51e-05 | 258 | 146 | 9 | M2446 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN | 1.54e-05 | 197 | 146 | 8 | M8303 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN | 1.71e-05 | 200 | 146 | 8 | M8257 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP | 1.71e-05 | 200 | 146 | 8 | M4031 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 2.22e-05 | 271 | 146 | 9 | MM1075 | |
| Coexpression | LIEN_BREAST_CARCINOMA_METAPLASTIC | 3.33e-05 | 33 | 146 | 4 | M11654 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 3.40e-05 | 109 | 146 | 6 | MM1214 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_0HR | 4.22e-05 | 69 | 146 | 5 | MM1024 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 6.97e-05 | 180 | 146 | 7 | M8239 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN | CETN2 MATK EWSR1 YBX3 BCL11A LYST PHB1 MSH6 ESYT2 NOP14 MTHFD2L ISG20L2 UBASH3B FSCN1 MARCKS SOD2 SORD | 7.53e-05 | 1045 | 146 | 17 | M8525 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYH10 CENPE BCLAF1 DNAJC7 LGALS8 BPTF TDRD3 PPP2R3A MKI67 LUM CPLANE1 DHX29 TOP2B | 8.12e-05 | 656 | 146 | 13 | M18979 |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | ELOA CAMK2D RTF2 EWSR1 ARID1A ZBTB1 LIN28A ADH1A LGALS8 ADH1B ADH1C MSH6 OAF MAPKAPK3 RBM5 TSHZ1 HADHA ARHGAP45 TOP2B | 9.10e-05 | 1277 | 146 | 19 | MM1032 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | CETN2 MATK U2AF2 ITPRID2 DNAJC7 MSH6 PPP2R1B GTF2I VPS33B B3GNT2 RBM5 HADHA EIF3C FSCN1 TOP1 MARCKS SOD2 STOML2 TTC33 SORD | 1.01e-04 | 1399 | 146 | 20 | M535 |
| Coexpression | GSE22045_TREG_VS_TCONV_DN | 1.01e-04 | 191 | 146 | 7 | M4401 | |
| Coexpression | GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 1.30e-04 | 199 | 146 | 7 | M8299 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN | 1.30e-04 | 199 | 146 | 7 | M7190 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 1.30e-04 | 199 | 146 | 7 | M3912 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_DC_UP | 1.30e-04 | 199 | 146 | 7 | M5143 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 1.30e-04 | 199 | 146 | 7 | M6645 | |
| Coexpression | GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN | 1.30e-04 | 199 | 146 | 7 | M3093 | |
| Coexpression | ALK_DN.V1_DN | 1.32e-04 | 139 | 146 | 6 | M2773 | |
| Coexpression | GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP | 1.34e-04 | 200 | 146 | 7 | M3663 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.64e-04 | 276 | 146 | 8 | M3063 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | 1.91e-04 | 359 | 146 | 9 | M15193 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | MYH10 WAPL CENPE BCLAF1 POLE YBX3 ARID1A CEP128 ZBTB1 KIAA0753 GVINP1 VPS33B NAF1 CEP135 MKI67 MTHFD2L ASB4 LUM CPLANE1 TOP1 LRIF1 MARCKS TOP2B | 1.34e-05 | 1252 | 145 | 23 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.02e-05 | 92 | 145 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ZWILCH MYH10 WAPL CENPE BCLAF1 POLE YBX3 BCL11A ARID1A CEP128 BPTF MSH6 TDRD3 VPS33B NAF1 CEP135 MKI67 MTHFD2L CPLANE1 TOP1 LRIF1 MARCKS | 4.39e-05 | 1257 | 145 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.44e-05 | 187 | 145 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ZWILCH MYH10 WAPL CENPE BCLAF1 POLE YBX3 BCL11A ARID1A CEP128 LIN28A BPTF MSH6 TDRD3 VPS33B PCDH19 NAF1 CEP135 MKI67 MTHFD2L CPLANE1 TOP1 LRIF1 MARCKS | 5.11e-05 | 1459 | 145 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | WAPL CENPE BCLAF1 POLE YBX3 BIRC6 ZBTB1 MSH6 NOP14 CEP135 GIGYF2 EIF3C TOP1 | 7.53e-05 | 532 | 145 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.05e-04 | 271 | 145 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-08 | 199 | 146 | 9 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | distal-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-08 | 199 | 146 | 9 | af226a6c50747dad9ca696463e715913b3ac17c0 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|COVID-19_Mild / Disease condition and Cell class | 7.57e-08 | 165 | 146 | 8 | ef709c5d3231c65d351316e1e31b9c9eba721628 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.52e-07 | 193 | 146 | 8 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.95e-07 | 197 | 146 | 8 | da653dc7d216e202f390e5ab0245f243e3ed213b | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-07 | 198 | 146 | 8 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.06e-07 | 198 | 146 | 8 | 5080767ff55326b7d94fca27d398237c4a15c1ed | |
| ToppCell | distal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.06e-07 | 198 | 146 | 8 | ce05ede69c167b2294630709bb0c223483a6ef75 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.18e-07 | 199 | 146 | 8 | 471738f2059e20407572d9c4cbd11812068333ea | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.18e-07 | 199 | 146 | 8 | 706b7de777ff86eb22e538ccd5c2987ceb6be308 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.18e-07 | 199 | 146 | 8 | 690a4f84b205532c4c9e5c19d5ae430d0655f421 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.30e-07 | 200 | 146 | 8 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 1.40e-06 | 168 | 146 | 7 | d50078614f7af74dc2aa4081c1708a5156ac51cf | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-06 | 171 | 146 | 7 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-06 | 171 | 146 | 7 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-06 | 172 | 146 | 7 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 174 | 146 | 7 | 7fb7bdf62563f2102fb38618b503eb2817b6594f | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 175 | 146 | 7 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-06 | 175 | 146 | 7 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 175 | 146 | 7 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-06 | 182 | 146 | 7 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 2.47e-06 | 183 | 146 | 7 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.85e-06 | 187 | 146 | 7 | 406ff9327d3109fe1e251629c4c617b00a573dc2 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-06 | 188 | 146 | 7 | b1ec7c45aedcc3d22cac898c6a3679e7f8b44c77 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 3.28e-06 | 191 | 146 | 7 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 192 | 146 | 7 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.51e-06 | 193 | 146 | 7 | 360079cbaa18b74e4a48c5de40844faca076e1a6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 194 | 146 | 7 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-06 | 195 | 146 | 7 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 3.89e-06 | 196 | 146 | 7 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-06 | 196 | 146 | 7 | f78951b460913866d092ba92af70ea76a2afa73e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-06 | 196 | 146 | 7 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-06 | 196 | 146 | 7 | 69ad90a429af4dad5a45556544224001ebcb1607 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-06 | 196 | 146 | 7 | 208ddedd29e1b9ca89cbb9b527c2e193a44cada2 | |
| ToppCell | Control-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 3.89e-06 | 196 | 146 | 7 | 1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-06 | 196 | 146 | 7 | 4da96672a9c72268cfcc82d61eb3caae6e02d4c4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-06 | 196 | 146 | 7 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.16e-06 | 198 | 146 | 7 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | distal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.16e-06 | 198 | 146 | 7 | 37ce7b485ffb207e75afd1b576b486c6d59fc136 | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 4.16e-06 | 198 | 146 | 7 | 3d76393e72eed59b4dd16130ef5dd1d331ba5711 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.16e-06 | 198 | 146 | 7 | 8d1c74a728040386316fbdcabcdea5fb2b5a76a1 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.16e-06 | 198 | 146 | 7 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-06 | 198 | 146 | 7 | e967c601101361fc1c48dab0e5b76dc68813276e | |
| ToppCell | distal-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.44e-06 | 200 | 146 | 7 | 65a50f03b0027ccefb51b8f77afa283d4a3b3567 | |
| ToppCell | (6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.44e-06 | 200 | 146 | 7 | f9baef67dde62f1c161a9408a78f635ea70ea9d3 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | (6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.44e-06 | 200 | 146 | 7 | f0818821c495022569aef2c1886d9f2446dc027e | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 4.44e-06 | 200 | 146 | 7 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.44e-06 | 200 | 146 | 7 | f09eaa52e11262ec47f3dcb4d890e240eaaa2b3d | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.44e-06 | 200 | 146 | 7 | c1d9748aaae489d26e24602a5dcbe7f5fa9a5548 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-06 | 200 | 146 | 7 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.44e-06 | 200 | 146 | 7 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.44e-06 | 200 | 146 | 7 | 6a5047018b12be3bc4b55a64d42e52e96c624003 | |
| ToppCell | medial-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.44e-06 | 200 | 146 | 7 | 16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.80e-06 | 143 | 146 | 6 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 156 | 146 | 6 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 157 | 146 | 6 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 162 | 146 | 6 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 162 | 146 | 6 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 162 | 146 | 6 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.76e-05 | 165 | 146 | 6 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.89e-05 | 167 | 146 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.95e-05 | 168 | 146 | 6 | 76b49463895cdef27c90f831c6246bcb92b9761b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 171 | 146 | 6 | 59d79c3e36a4930af42ebc96f05570641b9fb864 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.16e-05 | 171 | 146 | 6 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 173 | 146 | 6 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 173 | 146 | 6 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 173 | 146 | 6 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 173 | 146 | 6 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 174 | 146 | 6 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 174 | 146 | 6 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 2.46e-05 | 175 | 146 | 6 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 179 | 146 | 6 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 179 | 146 | 6 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|COVID-19_Severe / Disease condition and Cell class | 2.97e-05 | 181 | 146 | 6 | 0d07a67e8ee3bca687b378afbc4044434e63556d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 181 | 146 | 6 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 181 | 146 | 6 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.97e-05 | 181 | 146 | 6 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.97e-05 | 181 | 146 | 6 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 181 | 146 | 6 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 183 | 146 | 6 | 8d45dff06a199b1369576657f7f9dc0249c5f841 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 183 | 146 | 6 | 421265fa15d5a028cb567bb0904e670473ef102b | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-05 | 184 | 146 | 6 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-05 | 184 | 146 | 6 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 3.25e-05 | 184 | 146 | 6 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.25e-05 | 184 | 146 | 6 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.25e-05 | 184 | 146 | 6 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.35e-05 | 185 | 146 | 6 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | (5)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.46e-05 | 186 | 146 | 6 | acbca8cc048d87faf859b3e77bdb38d0a3dad71c | |
| ToppCell | (5)_Pericytes-(50)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.46e-05 | 186 | 146 | 6 | 67b59defdd1ed3608229cc5e2a3b480d92312afa | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.56e-05 | 187 | 146 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 187 | 146 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.56e-05 | 187 | 146 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-05 | 188 | 146 | 6 | 2c4e791df69a9df29922f9117e5cac7787c129ce | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.78e-05 | 189 | 146 | 6 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| Computational | Genes in the cancer module 514. | 1.60e-06 | 10 | 103 | 4 | MODULE_514 | |
| Computational | Genes in the cancer module 286 | 2.50e-05 | 37 | 103 | 5 | MODULE_286 | |
| Computational | Oxidoreductases. | 5.09e-05 | 22 | 103 | 4 | MODULE_373 | |
| Computational | Muscle genes. | 4.12e-04 | 37 | 103 | 4 | MODULE_512 | |
| Drug | CQ-S | 5.69e-08 | 17 | 145 | 5 | CID000072462 | |
| Drug | N-heptylformamide | 1.08e-07 | 8 | 145 | 4 | CID000347402 | |
| Drug | 2-NA | 1.94e-07 | 9 | 145 | 4 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 1.94e-07 | 9 | 145 | 4 | CID000440672 | |
| Drug | 4-Iodopyrazole | 2.53e-07 | 3 | 145 | 3 | DB02721 | |
| Drug | AC1L1J0I | 7.51e-07 | 12 | 145 | 4 | CID000030201 | |
| Drug | hexa-2,4-dien-1-ol | 7.51e-07 | 12 | 145 | 4 | CID000008104 | |
| Drug | Fomepizole | 1.01e-06 | 4 | 145 | 3 | DB01213 | |
| Drug | 2-naphthaldehyde | 1.08e-06 | 13 | 145 | 4 | CID000006201 | |
| Drug | naphthalenemethanol | 1.50e-06 | 14 | 145 | 4 | CID000020908 | |
| Drug | cysteinylglycine | 1.67e-06 | 57 | 145 | 6 | CID000065270 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 2.04e-06 | 15 | 145 | 4 | CID000440673 | |
| Drug | phenoxyethanol | 2.71e-06 | 16 | 145 | 4 | CID000031236 | |
| Drug | naphthaldehyde | 2.71e-06 | 16 | 145 | 4 | CID000006195 | |
| Drug | 1ga8 | 2.85e-06 | 184 | 145 | 9 | CID000445801 | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 4.04e-06 | 192 | 145 | 9 | 1599_DN | |
| Drug | testosterone enanthate | SMG1 ELOA MYH3 CLUAP1 MYH11 BCLAF1 RRBP1 DNAJC7 BPTF UBN1 TSHZ1 HADHA LUM DHX29 MARCKS | 4.20e-06 | 575 | 145 | 15 | ctd:C004648 |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.98e-06 | 197 | 145 | 9 | 3456_DN | |
| Drug | AC1N9ZZC | 5.21e-06 | 149 | 145 | 8 | CID004369374 | |
| Drug | Nicotinamide-Adenine-Dinucleotide | 5.38e-06 | 40 | 145 | 5 | DB01907 | |
| Drug | C x F | 5.68e-06 | 19 | 145 | 4 | CID000013017 | |
| Drug | 2,2,2-trichloroethanol | 7.21e-06 | 73 | 145 | 6 | CID000008259 | |
| Drug | Ethylene Glycol | 8.68e-06 | 21 | 145 | 4 | ctd:D019855 | |
| Drug | NBQCl | 8.69e-06 | 7 | 145 | 3 | CID000134086 | |
| Drug | Ethanol | 8.69e-06 | 7 | 145 | 3 | DB00898 | |
| Drug | N-benzylformamide | 9.11e-06 | 76 | 145 | 6 | CID000080654 | |
| Drug | nifedipine | MYH3 MYH8 MYH10 MYH11 CYP2D7 BIRC6 RYR1 MKI67 CYP4F12 LUM TOP2B SOD2 | 1.46e-05 | 415 | 145 | 12 | CID000004485 |
| Drug | 2-butoxyethanol | 1.52e-05 | 24 | 145 | 4 | CID000008133 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.62e-05 | 174 | 145 | 8 | 5940_DN | |
| Drug | 4-methylpyrazole | 1.62e-05 | 84 | 145 | 6 | CID000003406 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.76e-05 | 176 | 145 | 8 | 1535_DN | |
| Drug | 4,5-diaminofluorescein | 1.80e-05 | 25 | 145 | 4 | CID010666340 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.83e-05 | 177 | 145 | 8 | 6340_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.99e-05 | 179 | 145 | 8 | 5822_DN | |
| Drug | ardisin | 2.07e-05 | 9 | 145 | 3 | CID000417291 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.24e-05 | 182 | 145 | 8 | 1891_DN | |
| Drug | fomepizole | 2.47e-05 | 27 | 145 | 4 | ctd:C010238 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.52e-05 | 185 | 145 | 8 | 5882_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.62e-05 | 186 | 145 | 8 | 5000_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; PC3; HG-U133A | 2.72e-05 | 187 | 145 | 8 | 448_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.17e-05 | 191 | 145 | 8 | 7503_DN | |
| Drug | dhmal | 3.31e-05 | 29 | 145 | 4 | CID000151725 | |
| Drug | 3-HB | 3.31e-05 | 29 | 145 | 4 | CID000007420 | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; PC3; HT_HG-U133A | 3.41e-05 | 193 | 145 | 8 | 7098_UP | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; HL60; HT_HG-U133A | 3.54e-05 | 194 | 145 | 8 | 3043_UP | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.54e-05 | 194 | 145 | 8 | 4602_DN | |
| Drug | AC1L1AOQ | 3.80e-05 | 30 | 145 | 4 | CID000001082 | |
| Drug | InsS6 | 3.80e-05 | 30 | 145 | 4 | CID000065302 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; HL60; HT_HG-U133A | 3.95e-05 | 197 | 145 | 8 | 2547_DN | |
| Drug | 3-nitropropionic acid; Up 200; 10uM; MCF7; HT_HG-U133A | 3.95e-05 | 197 | 145 | 8 | 6367_UP | |
| Drug | A37536 | 4.02e-05 | 11 | 145 | 3 | CID000130471 | |
| Drug | methyl brevifolincarboxylate | 4.03e-05 | 2 | 145 | 2 | CID005319518 | |
| Drug | AC1L2J0B | 4.03e-05 | 2 | 145 | 2 | CID000072943 | |
| Drug | Ethylene Glycols | 4.03e-05 | 2 | 145 | 2 | ctd:D005026 | |
| Drug | Cyclohexylformamide | 4.03e-05 | 2 | 145 | 2 | DB03559 | |
| Drug | A 62176 | 4.03e-05 | 2 | 145 | 2 | CID000132823 | |
| Drug | 5-BMF | 4.03e-05 | 2 | 145 | 2 | CID000132858 | |
| Drug | Kt 6528 | 4.03e-05 | 2 | 145 | 2 | CID000132714 | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 1uM; MCF7; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 4384_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 7135_DN | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 4.24e-05 | 199 | 145 | 8 | 6069_DN | |
| Drug | S-(-)-Etomoxir | 4.38e-05 | 100 | 145 | 6 | CID000060765 | |
| Drug | trifluoperazine | 4.49e-05 | 324 | 145 | 10 | CID000005566 | |
| Drug | willardine | 4.94e-05 | 32 | 145 | 4 | CID000005123 | |
| Drug | allyl alcohol | 5.51e-05 | 64 | 145 | 5 | CID000007858 | |
| Drug | nocodazole | MYH3 MYH8 MYH10 MYH11 SPTB APC2 LGALS8 PHB1 PPP2R1B PPP2R3A HAUS1 CALY | 5.68e-05 | 477 | 145 | 12 | CID000004122 |
| Drug | 3-methylbutanal | 6.91e-05 | 13 | 145 | 3 | CID000011552 | |
| Drug | reduced diphosphopyridine nucleotide | 7.05e-05 | 342 | 145 | 10 | CID000000928 | |
| Drug | carvedilol | 7.91e-05 | 161 | 145 | 7 | CID000002585 | |
| Drug | DOPEG | 7.93e-05 | 36 | 145 | 4 | CID000091528 | |
| Drug | NSC611747 | MYH3 MYH8 MYH10 MYH11 BCLAF1 CAMK2D PHB1 PPP2R1B PPP2R3A CALY | 8.94e-05 | 352 | 145 | 10 | CID000002534 |
| Drug | 3-hydroxyoctanoate | 1.09e-04 | 15 | 145 | 3 | CID000026613 | |
| Drug | ANDs | 1.09e-04 | 15 | 145 | 3 | CID000129830 | |
| Drug | 2-Propanol | 1.09e-04 | 39 | 145 | 4 | ctd:D019840 | |
| Drug | polyporenic acid C | 1.20e-04 | 3 | 145 | 2 | CID005320667 | |
| Drug | NSC37726 | 1.20e-04 | 3 | 145 | 2 | CID000003302 | |
| Drug | U-1373 | 1.20e-04 | 3 | 145 | 2 | CID000102133 | |
| Drug | AC1L8X3U | 1.20e-04 | 3 | 145 | 2 | CID000409532 | |
| Drug | monomethyl phthalate | SPTB ARID1A LIN28A ADH1B ADH1C MSH6 PPP2R1B GTF2I TIAM1 P4HB MTHFR SUGP1 FSCN1 TOP1 TOP2B ANAPC4 PLCE1 | 1.30e-04 | 957 | 145 | 17 | ctd:C517284 |
| Drug | carbachol | MYH3 MYH8 MYH10 MYH11 CAMK2D MATK GCNT2 ADCY5 RYR1 HAUS1 GUCA2A P4HB SOD2 PLCE1 | 1.32e-04 | 688 | 145 | 14 | CID000002551 |
| Drug | isopropanol | 1.33e-04 | 122 | 145 | 6 | CID000003776 | |
| Drug | SAHA; Down 200; 10uM; PC3; HT_HG-U133A | 1.33e-04 | 175 | 145 | 7 | 1220_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.38e-04 | 176 | 145 | 7 | 1212_DN | |
| Drug | 2bq7 | 1.39e-04 | 123 | 145 | 6 | CID006540267 | |
| Drug | fast white | 1.46e-04 | 42 | 145 | 4 | CID000024008 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 1.48e-04 | 178 | 145 | 7 | 6193_DN | |
| Drug | fisetin; Down 200; 50uM; PC3; HG-U133A | 1.48e-04 | 178 | 145 | 7 | 579_DN | |
| Drug | rifampicin | 1.56e-04 | 306 | 145 | 9 | CID005381226 | |
| Drug | 2-chloro-dATP | 1.61e-04 | 17 | 145 | 3 | CID000122644 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 1.70e-04 | 182 | 145 | 7 | 1951_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.76e-04 | 183 | 145 | 7 | 7498_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 1.76e-04 | 183 | 145 | 7 | 7062_DN | |
| Drug | zoxazolamine | 1.76e-04 | 44 | 145 | 4 | CID000006103 | |
| Drug | AC1L9FX4 | 1.76e-04 | 44 | 145 | 4 | CID000444209 | |
| Drug | chloral hydrate | 1.80e-04 | 129 | 145 | 6 | CID000002707 | |
| Drug | 8-oxyguanine | 1.88e-04 | 130 | 145 | 6 | CID000119315 | |
| Drug | benzyl alcohol | 1.90e-04 | 83 | 145 | 5 | CID000000244 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 1.94e-04 | 186 | 145 | 7 | 2694_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 187 | 145 | 7 | 4989_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.07e-04 | 188 | 145 | 7 | 1213_DN | |
| Disease | alcohol dependence measurement | 6.89e-06 | 55 | 142 | 5 | EFO_0007835 | |
| Disease | Alcoholic Intoxication | 1.66e-05 | 32 | 142 | 4 | C0001969 | |
| Disease | Benign Neoplasm | 1.96e-05 | 68 | 142 | 5 | C0086692 | |
| Disease | Neoplasms | 1.96e-05 | 68 | 142 | 5 | C0027651 | |
| Disease | Carcinoma, Granular Cell | 2.15e-05 | 116 | 142 | 6 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.15e-05 | 116 | 142 | 6 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.15e-05 | 116 | 142 | 6 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.15e-05 | 116 | 142 | 6 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.15e-05 | 116 | 142 | 6 | C0205641 | |
| Disease | Adenocarcinoma | 2.15e-05 | 116 | 142 | 6 | C0001418 | |
| Disease | mitochondrial complex V (ATP synthase) deficiency nuclear type 3 (implicated_via_orthology) | 2.30e-05 | 2 | 142 | 2 | DOID:0060332 (implicated_via_orthology) | |
| Disease | X-11444 measurement | 3.01e-05 | 13 | 142 | 3 | EFO_0021237 | |
| Disease | Colorectal Carcinoma | POLE APC2 ARID1A ADH1B MSH6 PPP2R1B TIAM1 MTHFR MCM3AP CPO MKI67 SOD2 ANAPC4 | 3.67e-05 | 702 | 142 | 13 | C0009402 |
| Disease | Malignant Neoplasms | 3.74e-05 | 128 | 142 | 6 | C0006826 | |
| Disease | Replication Error Phenotype | 4.76e-05 | 15 | 142 | 3 | C1721098 | |
| Disease | Microsatellite Instability | 4.76e-05 | 15 | 142 | 3 | C0920269 | |
| Disease | age at menopause | 1.13e-04 | 302 | 142 | 8 | EFO_0004704 | |
| Disease | Mouth Neoplasms | 1.35e-04 | 54 | 142 | 4 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 1.35e-04 | 54 | 142 | 4 | C0153381 | |
| Disease | Multiple pterygium syndrome | 1.37e-04 | 4 | 142 | 2 | C0265261 | |
| Disease | Myelocele | 1.37e-04 | 4 | 142 | 2 | C0086664 | |
| Disease | Meningomyelocele | 1.37e-04 | 4 | 142 | 2 | C0025312 | |
| Disease | intestinal disease (implicated_via_orthology) | 1.37e-04 | 4 | 142 | 2 | DOID:5295 (implicated_via_orthology) | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 1.37e-04 | 4 | 142 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Acquired Meningomyelocele | 1.37e-04 | 4 | 142 | 2 | C0751316 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 2.05e-04 | 24 | 142 | 3 | EFO_0009458, MONDO_0007079 | |
| Disease | pancreatic cancer (is_implicated_in) | 2.13e-04 | 112 | 142 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | Alcohol dependence | 2.28e-04 | 5 | 142 | 2 | cv:C0001973 | |
| Disease | mucositis (biomarker_via_orthology) | 2.28e-04 | 5 | 142 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | ALCOHOL DEPENDENCE | 2.28e-04 | 5 | 142 | 2 | 103780 | |
| Disease | hypertension, pregnancy-induced | 2.28e-04 | 5 | 142 | 2 | MONDO_0024664 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.61e-04 | 64 | 142 | 4 | DOID:4947 (is_marker_for) | |
| Disease | alcohol dependence | 2.67e-04 | 183 | 142 | 6 | MONDO_0007079 | |
| Disease | bilirubin measurement | 3.02e-04 | 442 | 142 | 9 | EFO_0004570 | |
| Disease | Alcoholic Intoxication, Chronic | 3.31e-04 | 268 | 142 | 7 | C0001973 | |
| Disease | cardiovascular disease | 3.86e-04 | 457 | 142 | 9 | EFO_0000319 | |
| Disease | esophageal carcinoma | 4.03e-04 | 30 | 142 | 3 | EFO_0002916 | |
| Disease | Colorectal Neoplasms | 4.03e-04 | 277 | 142 | 7 | C0009404 | |
| Disease | Endometrial Carcinoma | 4.10e-04 | 72 | 142 | 4 | C0476089 | |
| Disease | alcoholic liver cirrhosis (is_implicated_in) | 4.75e-04 | 7 | 142 | 2 | DOID:14018 (is_implicated_in) | |
| Disease | OROFACIODIGITAL SYNDROME VI | 4.75e-04 | 7 | 142 | 2 | C2745997 | |
| Disease | fatty liver disease (is_implicated_in) | 4.75e-04 | 7 | 142 | 2 | DOID:9452 (is_implicated_in) | |
| Disease | cathepsin Z measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0008074 | |
| Disease | ovarian cancer (implicated_via_orthology) | 6.32e-04 | 8 | 142 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | coronary artery disease | MYH11 HSF2BP YBX3 RRBP1 PHB1 PPP2R1B PPP2R3A VPS33B MTHFR B3GNT2 CEP135 GIGYF2 RPRD2 UBASH3B PLCE1 | 6.58e-04 | 1194 | 142 | 15 | EFO_0001645 |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 7.52e-04 | 37 | 142 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | Distal arthrogryposis | 8.10e-04 | 9 | 142 | 2 | cv:C0265213 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 8.10e-04 | 9 | 142 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 9.70e-04 | 156 | 142 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 9.70e-04 | 156 | 142 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 9.70e-04 | 156 | 142 | 5 | C2585653 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Atrial Fibrillation | 1.09e-03 | 160 | 142 | 5 | C0004238 | |
| Disease | liver fat measurement | 1.17e-03 | 43 | 142 | 3 | EFO_0010821 | |
| Disease | Barrett's esophagus (is_marker_for) | 1.23e-03 | 11 | 142 | 2 | DOID:9206 (is_marker_for) | |
| Disease | Alcohol Use Disorder | 1.25e-03 | 44 | 142 | 3 | C0001956 | |
| Disease | upper aerodigestive tract neoplasm | 1.26e-03 | 246 | 142 | 6 | EFO_0004284 | |
| Disease | urate measurement | POLE GCNT2 ARID1A BIRC6 ADH1B PPP2R1B SPATS2L OAF TOP1 ANAPC4 TTC33 SORD | 1.34e-03 | 895 | 142 | 12 | EFO_0004531 |
| Disease | pancreatic cancer (is_marker_for) | 1.46e-03 | 101 | 142 | 4 | DOID:1793 (is_marker_for) | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 1.47e-03 | 12 | 142 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | 11beta-hydroxyandrosterone glucuronide measurement | 1.47e-03 | 12 | 142 | 2 | EFO_0800573 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.47e-03 | 12 | 142 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.47e-03 | 12 | 142 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.73e-03 | 13 | 142 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Antihypertensive use measurement | 1.83e-03 | 265 | 142 | 6 | EFO_0009927 | |
| Disease | cancer (implicated_via_orthology) | 1.94e-03 | 268 | 142 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Tubular Aggregate Myopathy | 2.01e-03 | 14 | 142 | 2 | C0410207 | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 2.01e-03 | 14 | 142 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | atrial fibrillation | 2.19e-03 | 371 | 142 | 7 | EFO_0000275 | |
| Disease | platelet crit | RRBP1 ARID1A ADCY5 LGALS8 TULP4 NAV3 RPRD2 ISG20L2 PLEC UBASH3B KLRC2 PLCE1 | 2.24e-03 | 952 | 142 | 12 | EFO_0007985 |
| Disease | Peripheral Nervous System Diseases | 2.26e-03 | 54 | 142 | 3 | C4721453 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.32e-03 | 15 | 142 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Autosomal recessive primary microcephaly | 2.32e-03 | 15 | 142 | 2 | cv:C3711387 | |
| Disease | unipolar depression, cognitive function measurement | 2.32e-03 | 15 | 142 | 2 | EFO_0003761, EFO_0008354 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 2.32e-03 | 15 | 142 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | waist-hip ratio | MYH11 DGKG YTHDC2 BCL11A BIRC6 ADCY5 ADH1B BPTF PPP2R1B PPP2R3A UBN1 NAV3 TOP1 PLCE1 | 2.43e-03 | 1226 | 142 | 14 | EFO_0004343 |
| Disease | response to calcium channel blocker | 2.51e-03 | 56 | 142 | 3 | EFO_0007767 | |
| Disease | alcohol use disorder (is_implicated_in) | 2.64e-03 | 16 | 142 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | phosphatidylcholine 38:6 measurement | 2.64e-03 | 16 | 142 | 2 | EFO_0010388 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 2.64e-03 | 16 | 142 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | sickle cell anemia (is_implicated_in) | 2.64e-03 | 16 | 142 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | fibrinogen measurement, factor VII measurement | 2.77e-03 | 58 | 142 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | Endometrial Neoplasms | 2.77e-03 | 58 | 142 | 3 | C0014170 | |
| Disease | high altitude adaptation | 2.98e-03 | 17 | 142 | 2 | EFO_0009105 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 2.98e-03 | 17 | 142 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | Necrotizing Enterocolitis | 2.98e-03 | 17 | 142 | 2 | C0520459 | |
| Disease | Psychoses, Substance-Induced | 2.98e-03 | 17 | 142 | 2 | C0033941 | |
| Disease | graft-versus-host disease (is_implicated_in) | 2.98e-03 | 17 | 142 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | Vascular Diseases | 2.98e-03 | 17 | 142 | 2 | C0042373 | |
| Disease | triglycerides in small VLDL measurement | 3.20e-03 | 61 | 142 | 3 | EFO_0022145 | |
| Disease | Post-Traumatic Osteoporosis | 3.20e-03 | 61 | 142 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 3.20e-03 | 61 | 142 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 3.20e-03 | 61 | 142 | 3 | C0001787 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAASKLGEFAKVLEL | 196 | P30154 | |
| DGKDFQGSKLKVSLA | 431 | Q01844 | |
| DVAVKNSGGFLSKDK | 871 | A0FGR8 | |
| IGKEIDAACKTFSKD | 831 | Q6ZU80 | |
| DGKLLAFALADTKKI | 76 | Q9UJX5 | |
| SLLAKVAAGKEKSSN | 1261 | Q9NR09 | |
| KSSFVGDGDIFKKLD | 1316 | O14514 | |
| NKDKFAKAKELGATE | 226 | P07327 | |
| NSEKFVKAKALGATD | 231 | P08319 | |
| FLEALKSNDFGKLKA | 21 | Q9Y574 | |
| LGDKDKSLEVSKNAA | 321 | Q9UNA0 | |
| NKDKFAKAKELGATE | 226 | P00325 | |
| NKDKFAKAKELGATE | 226 | P00326 | |
| VAAVFDKVSEKLGDK | 1466 | Q7Z2Y8 | |
| DKVLFDNTGRGKSKS | 216 | Q9BXS5 | |
| KAGDLASLKKAFESG | 501 | Q9NU02 | |
| DKVGKTHIKALADFA | 1141 | O95622 | |
| ALKTEFKANAEKTSG | 26 | P56381 | |
| ALEAFETFKKGLGLK | 331 | Q00796 | |
| KSAEAGIAGEAQSKK | 26 | Q7Z478 | |
| ILKAFKLFDDDETGK | 106 | P41208 | |
| KLFDDDETGKISFKN | 111 | P41208 | |
| AAAAHEANKLFKEGK | 796 | Q12830 | |
| KSKTKGNDFFIDDSK | 1331 | Q12830 | |
| KAVASFIESKKDDIL | 216 | Q8IVL8 | |
| ALKTEFKANAKKTSG | 26 | Q5VTU8 | |
| DALKTGITAAKEKFD | 421 | P23786 | |
| KAKAKSLSEAFENLG | 491 | Q8NCD3 | |
| VKIFAKGTLANSASK | 916 | Q149M9 | |
| QKKAAIISAEGDSKA | 206 | P35232 | |
| DIFAAADSKKSQPKI | 1116 | O14497 | |
| KSFKAQFGKDLTETL | 61 | P13928 | |
| TKAFEFKVLAKDGGL | 526 | Q8TAB3 | |
| LKHLKEKVSAGADFI | 211 | P42898 | |
| KAGVAILVSDKTDFK | 71 | O00370 | |
| LAKDSLKAEAEAKAA | 856 | Q92619 | |
| AKVSDFGLAKAERKG | 366 | P42679 | |
| TKGNKIAGFDSIDKK | 1646 | Q86YW9 | |
| SKEKDAVLKLTDFGF | 176 | Q16644 | |
| KTGFAEDDRKAFASK | 1321 | Q9BY89 | |
| SDAEFKKIFGLTKDL | 566 | Q5T3J3 | |
| SLQEKEKASRKGSFG | 1501 | Q6PRD1 | |
| AKSFNVDLLAGKSKD | 211 | O00214 | |
| KATDAFKGAVKQLLS | 131 | Q8N0V5 | |
| GNKEAKKETGFVESA | 356 | O60318 | |
| SALKSVVAKFKSEND | 461 | Q9H165 | |
| KSLTDKGFFANTDKK | 1326 | Q5CZC0 | |
| KGFFANTDKKLESLV | 1331 | Q5CZC0 | |
| KFEKKFQSEKAAGSV | 16 | Q9Y3D6 | |
| GQFIDSKKASEKLLA | 736 | P13535 | |
| GSTKLSDKDKAVGIF | 266 | P47881 | |
| ADKKKNAVVFKSDGS | 451 | Q02817 | |
| AAAGKKTLVSKFFDV | 246 | Q9HCR9 | |
| KLVKDVKAFAGASAG | 31 | P41247 | |
| KSGRKKTEDAIATFN | 2076 | Q8IVL0 | |
| SKKADSVAAKVDLLG | 106 | Q9H9L3 | |
| KKKLSAAVEVGDAAE | 776 | Q07864 | |
| ETAGDGKSIKAFKES | 2031 | P46013 | |
| KLSNFKTAAESFKGK | 271 | P07237 | |
| SKKKIIDFLSALEGF | 851 | P52701 | |
| SLAEGNKAKLEKLFG | 461 | P78316 | |
| DGNFSFSLESVKKLK | 26 | Q02747 | |
| KAAAVADKRKSGSQD | 581 | P28290 | |
| SGKIKEFSFEKLKNS | 121 | Q06190 | |
| KTIGVDFAKSARKDL | 306 | P52756 | |
| AFITKVKKGSLADTV | 696 | Q9UQ26 | |
| KLSAVKAEKESANFD | 51 | Q66GS9 | |
| EDEDGVSAATFLKKK | 186 | Q99613 | |
| KKIKDALTEFNEGGS | 26 | P49619 | |
| EDEDGVSAATFLKKK | 186 | B5ME19 | |
| EAAVAAKAKAKLALA | 836 | O95996 | |
| KSFKAQFGKDLTETL | 61 | Q5VT79 | |
| SAKAEKEAARKAAGS | 196 | Q9NYX4 | |
| KAGKATKVGKDELFA | 241 | Q16658 | |
| DSSGAFLSLKKVQKE | 301 | Q6Y7W6 | |
| LPVKENKDFSGAAKS | 906 | Q9H799 | |
| VFSLGIKAADAKELK | 271 | Q99715 | |
| KAKLDKSKQGLDSFD | 361 | Q14241 | |
| GDQETAKTGKFLKRF | 326 | Q9NYF8 | |
| FGLVDSEKDAAVAKK | 106 | P31415 | |
| QGIDDFFKDKAKSKT | 281 | Q9HCS2 | |
| ADRTFKKAAGAEEKK | 306 | O00257 | |
| LKEDAVSAAFKGLKS | 171 | P51884 | |
| GSSDTLKKGKEDAFI | 2151 | Q99698 | |
| LSGFSFKKNKKEAGE | 166 | P29966 | |
| KKFKEVGEAFTILSD | 426 | Q99615 | |
| EEVAITFAKGLADKK | 241 | P40939 | |
| FATFDKGVAKKLSLK | 196 | O14958 | |
| KKFAEALGSTEAKAV | 476 | P78347 | |
| GKKFSKEFEEASSKL | 236 | Q5VT52 | |
| SKAEKKATVDAEGNF | 2721 | P21817 | |
| TFALKGKVLDFKAID | 1966 | Q6ZTR5 | |
| SKEAQKFDSSLGALK | 851 | Q02224 | |
| KKGIKFAKDAASLES | 1301 | P35580 | |
| GAVKSKFKATISALE | 1806 | P35580 | |
| SKSKGAAVKLADFGL | 146 | Q13557 | |
| LKIASVEGRKKAFAT | 236 | P30954 | |
| LSESKEQEFGKLFSK | 161 | Q9Y316 | |
| LLDKSAEKALGKAAS | 66 | Q9BY42 | |
| VKAILGGDKALKFFS | 141 | O75031 | |
| SFSNTDKKAKVGLEA | 541 | Q8IWZ5 | |
| AAIAEVAKSKETKTF | 136 | Q9H7E2 | |
| DDAAITLAFSKKKID | 666 | Q02880 | |
| KKGDLDTAAVKVEFD | 1261 | Q02880 | |
| VDSSVKKIKAAFAEL | 246 | Q9NUQ6 | |
| TINGLAFKHKIKDSD | 186 | P26717 | |
| ASREDKKKGISFASE | 2241 | Q9P212 | |
| SENPAVAKKLFSAKA | 746 | Q96D09 | |
| KAKSEEFRFGIKAAE | 186 | Q96CS2 | |
| FGAESKVSVDDLCKK | 3126 | Q96Q15 | |
| VAGGARKATKSKLFE | 6 | Q6STE5 | |
| DTAFKNGLKDTKDAR | 261 | Q969V4 | |
| FATIAATGDLAKKKD | 196 | P11055 | |
| SLKVDDTGKKIFAVS | 176 | Q5VTB9 | |
| KLKGAAVKLADFGLA | 146 | Q9UQM7 | |
| SASFKDEVLAVAKTK | 476 | Q2KHM9 | |
| FKLKKKDTQGFGEES | 21 | Q9BQ49 | |
| GTLVSFTADFKKDVK | 66 | Q86UD1 | |
| DDDFTFGQSALKKIK | 171 | Q8N5C6 | |
| SLSKTKAKDLFIGDV | 261 | Q9NY97 | |
| KAAVIGLTKSVAADF | 151 | Q9BUT1 | |
| FKFDLGSKIADLKAA | 126 | Q96AJ1 | |
| LTEAFLAKKEKAKGS | 271 | A0A087X1C5 | |
| GAVKSKFKSTIAALE | 1806 | P35749 | |
| QKLEEFRKAKASSTG | 311 | Q8IWZ8 | |
| GKVKKEARTLSDFNS | 1356 | Q9NRJ4 | |
| LKKQASFLEAEGGAK | 361 | Q8WYP3 | |
| LNKLDGFGDSTKKDT | 306 | Q9H900 | |
| AAGSEDAEKKVLATK | 76 | P16989 | |
| AAEKAKAAAGEAKVK | 731 | Q9P2E9 | |
| LVKAKTDTAFKAFLD | 1156 | Q13009 | |
| REKEFKAKEAAALGS | 51 | O75348 | |
| SNTKSKKDVKLEFFG | 416 | Q7Z5K2 | |
| AGEASAVLAKAKAKA | 241 | Q9UJZ1 | |
| GDKVKAITAATLKFT | 581 | P11277 | |
| GSFDKFKEKLTAASV | 126 | P04179 | |
| ALKASFEKAAAGKAE | 2066 | Q15149 | |
| DVDFEAVKKKAGFIT | 306 | Q9H903 | |
| DSNIKAEFGEKDSSK | 261 | Q9Y2K1 | |
| SGKVKEKSFDALNFV | 706 | Q9H6S0 | |
| SKAGFTALNASKEKK | 221 | Q9NPG3 | |
| KAFNLVKDSATGLSK | 286 | P26368 | |
| FVKEDSAEVLKKFAA | 176 | Q8TF42 | |
| VASLALAQGSAKKFK | 321 | Q8TE54 | |
| ASGDAKIKKEKENGF | 96 | P11387 | |
| LAKAASPIAKENKDF | 666 | Q6ZSZ6 | |
| KLVTDKAAGKITDAF | 461 | Q9H267 | |
| KAAGKITDAFSSLAK | 466 | Q9H267 | |
| AEKSKQLKDEGASLA | 56 | Q6PID6 | |
| EAVEFTFKKSAKGLE | 91 | Q9H9Z2 | |
| KSGKSKGKDVNLAEF | 376 | Q9BRK3 | |
| IFTEKLKQDKGSDAS | 286 | Q96HR8 | |
| NKHAGKSKEEAKLAF | 2086 | Q13402 |